Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	pore-forming activity	DEFA1 DEFA3 DEFA4 PRF1	1.48e-07	10	105	4	GO:0140911
GeneOntologyMolecularFunction	transporter activity	ATP13A4 SLC38A4 SLC22A23 SLC26A5 SLC44A2 XKR8 SLC10A3 PKD1L2 SLC44A4 SLC7A14 SLC38A2 NALCN ABCA6 TRPM3 SLC2A6 PRF1 PKD1 TRPV6 TMEM41B SLC24A1 GRAMD1C ATP2B4	7.61e-07	1289	105	22	GO:0005215
GeneOntologyMolecularFunction	transmembrane transporter activity	ATP13A4 SLC38A4 SLC22A23 SLC26A5 SLC44A2 SLC10A3 PKD1L2 SLC44A4 SLC7A14 SLC38A2 NALCN ABCA6 TRPM3 SLC2A6 PRF1 PKD1 TRPV6 SLC24A1 ATP2B4	1.13e-05	1180	105	19	GO:0022857
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	ATP13A4 PKD1L2 TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	1.51e-05	151	105	7	GO:0015085
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	ATP13A4 SLC38A4 SLC10A3 PKD1L2 SLC38A2 NALCN TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	3.38e-05	465	105	11	GO:0046873
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	HTR4 TMEM116 GPR37 DDR2 GPR85 TMIGD3 LMBR1 CLEC4M TAS2R42 CELSR1 OR51I1 OR6C76 PKD1 OR1P1 TAS2R40 ACKR2 TAS2R39 GPRC5B EPHB1	7.36e-05	1353	105	19	GO:0004888
GeneOntologyMolecularFunction	alanine:sodium symporter activity	SLC38A4 SLC38A2	1.63e-04	4	105	2	GO:0015655
GeneOntologyMolecularFunction	active transmembrane transporter activity	ATP13A4 SLC38A4 SLC26A5 SLC44A2 SLC10A3 SLC44A4 SLC38A2 ABCA6 SLC24A1 ATP2B4	2.09e-04	477	105	10	GO:0022804
GeneOntologyMolecularFunction	G protein-coupled receptor activity	HTR4 TMEM116 GPR37 GPR85 TMIGD3 TAS2R42 CELSR1 OR51I1 OR6C76 OR1P1 TAS2R40 ACKR2 TAS2R39 GPRC5B	2.17e-04	884	105	14	GO:0004930
GeneOntologyMolecularFunction	bitter taste receptor activity	TAS2R42 TAS2R40 TAS2R39	3.77e-04	27	105	3	GO:0033038
GeneOntologyMolecularFunction	signaling receptor regulator activity	DEFB104A CXCL14 PF4V1 IFNA2 BGLAP THPO EFNA5 ASIP IGSF1 DEFB109B GNRH2	3.98e-04	616	105	11	GO:0030545
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	ATP13A4 SLC38A4 SLC10A3 PKD1L2 SLC38A2 NALCN TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	4.61e-04	627	105	11	GO:0022890
GeneOntologyMolecularFunction	calcium channel activity	PKD1L2 TRPM3 PKD1 TRPV6 SLC24A1	6.00e-04	129	105	5	GO:0005262
GeneOntologyMolecularFunction	receptor ligand activity	DEFB104A CXCL14 PF4V1 IFNA2 BGLAP THPO EFNA5 ASIP DEFB109B GNRH2	6.15e-04	547	105	10	GO:0048018
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	ATP13A4 SLC38A4 SLC26A5 SLC10A3 PKD1L2 SLC38A2 NALCN TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	6.32e-04	758	105	12	GO:0015318
GeneOntologyMolecularFunction	signaling receptor activator activity	DEFB104A CXCL14 PF4V1 IFNA2 BGLAP THPO EFNA5 ASIP DEFB109B GNRH2	6.79e-04	554	105	10	GO:0030546
GeneOntologyMolecularFunction	taste receptor activity	TAS2R42 TAS2R40 TAS2R39	6.87e-04	33	105	3	GO:0008527
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	ATP13A4 SLC38A4 SLC10A3 PKD1L2 SLC38A2 NALCN TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	7.42e-04	664	105	11	GO:0008324
GeneOntologyMolecularFunction	choline transmembrane transporter activity	SLC44A2 SLC44A4	7.51e-04	8	105	2	GO:0015220
GeneOntologyMolecularFunction	neutral L-amino acid:sodium symporter activity	SLC38A4 SLC38A2	7.51e-04	8	105	2	GO:0005295
GeneOntologyMolecularFunction	organic acid:sodium symporter activity	SLC38A4 SLC10A3 SLC38A2	8.18e-04	35	105	3	GO:0005343
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC38A4 SLC26A5 SLC10A3 SLC44A4 SLC7A14 SLC38A2 SLC2A6	9.11e-04	293	105	7	GO:0008514
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	ATP13A4 SLC38A4 SLC26A5 SLC10A3 PKD1L2 SLC38A2 NALCN TRPM3 PKD1 TRPV6 SLC24A1 ATP2B4	9.37e-04	793	105	12	GO:0015075
GeneOntologyMolecularFunction	organic cation transmembrane transporter activity	SLC38A4 SLC44A2 SLC44A4 SLC38A2	9.64e-04	83	105	4	GO:0015101
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC38A4 SLC26A5 SLC44A2 SLC10A3 SLC44A4 SLC38A2 SLC24A1	9.67e-04	296	105	7	GO:0015291
GeneOntologyMolecularFunction	active monoatomic ion transmembrane transporter activity	ATP13A4 SLC38A4 SLC26A5 SLC10A3 SLC38A2 SLC24A1 ATP2B4	1.07e-03	301	105	7	GO:0022853
GeneOntologyMolecularFunction	P-type calcium transporter activity	ATP13A4 ATP2B4	1.46e-03	11	105	2	GO:0005388
GeneOntologyMolecularFunction	platelet-derived growth factor binding	COL1A1 COL1A2	1.75e-03	12	105	2	GO:0048407
GeneOntologyMolecularFunction	sodium ion transmembrane transporter activity	SLC38A4 SLC10A3 SLC38A2 NALCN SLC24A1	2.10e-03	171	105	5	GO:0015081
GeneOntologyMolecularFunction	alanine transmembrane transporter activity	SLC38A4 SLC38A2	3.13e-03	16	105	2	GO:0022858
GeneOntologyMolecularFunction	lipid transporter activity	XKR8 SLC10A3 ABCA6 TMEM41B GRAMD1C	3.79e-03	196	105	5	GO:0005319
GeneOntologyBiologicalProcess	disruption of plasma membrane integrity in another organism	DEFA1 DEFA3 DEFA4	2.54e-06	6	105	3	GO:0051673
GeneOntologyBiologicalProcess	disruption of cellular anatomical structure in another organism	DEFA1 DEFA3 DEFA4	2.54e-06	6	105	3	GO:0140975
GeneOntologyBiologicalProcess	orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis	VANGL2 CELSR1	2.57e-05	2	105	2	GO:0060488
GeneOntologyBiologicalProcess	planar dichotomous subdivision of terminal units involved in lung branching morphogenesis	VANGL2 CELSR1	2.57e-05	2	105	2	GO:0060489
GeneOntologyBiologicalProcess	lateral sprouting involved in lung morphogenesis	VANGL2 CELSR1	2.57e-05	2	105	2	GO:0060490
GeneOntologyBiologicalProcess	plasma kallikrein-kinin cascade	F12 PRCP	7.68e-05	3	105	2	GO:0002353
GeneOntologyBiologicalProcess	dichotomous subdivision of terminal units involved in lung branching	VANGL2 CELSR1	7.68e-05	3	105	2	GO:0060448
GeneOntologyBiologicalProcess	cell chemotaxis	GBF1 DEFB104A CXCL14 PF4V1 ITGA1 DEFA1 ACKR2 DEFB109B EPHB1	9.98e-05	363	105	9	GO:0060326
GeneOntologyBiologicalProcess	immunological synapse formation	DOCK8 PRF1 EPHB1	1.17e-04	19	105	3	GO:0001771
GeneOntologyBiologicalProcess	establishment of body hair planar orientation	VANGL2 CELSR1	1.53e-04	4	105	2	GO:0048105
GeneOntologyBiologicalProcess	establishment of body hair or bristle planar orientation	VANGL2 CELSR1	1.53e-04	4	105	2	GO:0048104
GeneOntologyBiologicalProcess	calcium ion transmembrane transport	ATP13A4 PKD1L2 NALCN TRPM3 PKD1 UBR3 TRPV6 SLC24A1 ATP2B4	1.78e-04	392	105	9	GO:0070588
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	HTR4 TMEM116 GPR37 GPR85 TMIGD3 PF4V1 ADM5 TAS2R42 CELSR1 THPO OR51I1 OR6C76 OR1P1 TAS2R40 ACKR2 TAS2R39 ATP2B4 GPRC5B	2.25e-04	1395	105	18	GO:0007186
GeneOntologyBiologicalProcess	humoral immune response	SUSD4 CXCL14 PF4V1 IFNA2 DEFA1 DEFA3 DEFA4 RNASE4	2.38e-04	321	105	8	GO:0006959
GeneOntologyBiologicalProcess	defense response to other organism	SUSD4 DDX60 DEFB104A CXCL14 PF4V1 SIRPA CLEC4M IFNA2 F12 CD84 DEFA1 DEFA3 DEFA4 RNASE4 PRF1 DDX60L LY9 DEFB109B	2.49e-04	1407	105	18	GO:0098542
GeneOntologyBiologicalProcess	defense response to symbiont	SUSD4 DDX60 DEFB104A CXCL14 PF4V1 SIRPA CLEC4M IFNA2 F12 CD84 DEFA1 DEFA3 DEFA4 RNASE4 PRF1 DDX60L LY9	2.59e-04	1286	105	17	GO:0140546
GeneOntologyBiologicalProcess	calcium ion transport	ATP13A4 PKD1L2 CD84 NALCN TRPM3 PKD1 UBR3 TRPV6 SLC24A1 ATP2B4	2.72e-04	509	105	10	GO:0006816
GeneOntologyBiologicalProcess	response to mechanical stimulus	DDR2 SLC26A5 PKD1L2 BGLAP SLC38A2 PKD1 COL1A1	2.73e-04	247	105	7	GO:0009612
GeneOntologyBiologicalProcess	chemotaxis	GBF1 DEFB104A CXCL14 PF4V1 ITGA1 DEFA1 EFNA5 ACKR2 DEFB109B EPHB1	3.08e-04	517	105	10	GO:0006935
GeneOntologyBiologicalProcess	taxis	GBF1 DEFB104A CXCL14 PF4V1 ITGA1 DEFA1 EFNA5 ACKR2 DEFB109B EPHB1	3.17e-04	519	105	10	GO:0042330
GeneOntologyBiologicalProcess	negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	HFE SUSD4 PF4V1 IFNA2	3.59e-04	66	105	4	GO:0002823
GeneOntologyBiologicalProcess	kinin cascade	F12 PRCP	3.80e-04	6	105	2	GO:0002254
GeneOntologyBiologicalProcess	antimicrobial humoral response	CXCL14 PF4V1 DEFA1 DEFA3 DEFA4 RNASE4	3.81e-04	186	105	6	GO:0019730
GeneOntologyBiologicalProcess	innate immune response in mucosa	DEFA1 DEFA3 DEFA4	4.71e-04	30	105	3	GO:0002227
GeneOntologyBiologicalProcess	negative regulation of adaptive immune response	HFE SUSD4 PF4V1 IFNA2	4.74e-04	71	105	4	GO:0002820
GeneOntologyBiologicalProcess	leukocyte migration	GBF1 DOCK8 DEFB104A TMIGD3 CXCL14 PF4V1 SIRPA ITGA1 DEFA1	4.81e-04	449	105	9	GO:0050900
GeneOntologyBiologicalProcess	killing of cells of another organism	CXCL14 DEFA1 DEFA3 DEFA4 PRF1	5.19e-04	129	105	5	GO:0031640
GeneOntologyBiologicalProcess	disruption of cell in another organism	CXCL14 DEFA1 DEFA3 DEFA4 PRF1	5.19e-04	129	105	5	GO:0141061
GeneOntologyCellularComponent	collagen type I trimer	COL1A1 COL1A2	2.69e-05	2	109	2	GO:0005584
GeneOntologyCellularComponent	cell surface	HFE GPR37 DLK1 SIRPA ITGA1 CLEC4M CD84 EFNA5 PROM2 PKD1 CD53 ACKR2 LY9 SLC24A1 GPRC5B	6.46e-04	1111	109	15	GO:0009986
GeneOntologyCellularComponent	secretory granule	SPINK2 EQTN SLC44A2 PF4V1 SIRPA ITGA1 POMT1 HUWE1 DEFA1 DEFA3 DEFA4 PRCP CD53 COL1A1	7.98e-04	1014	109	14	GO:0030141
GeneOntologyCellularComponent	basal part of cell	HFE SLC26A5 ITGA1 VANGL2 PROM2 PRCP PKD1 ATP2B4	8.25e-04	378	109	8	GO:0045178
HumanPheno	Biconcave flattened vertebrae	COL1A1 COL1A2	3.58e-05	2	31	2	HP:0003321
HumanPheno	Absent ossification of calvaria	COL1A1 COL1A2	3.58e-05	2	31	2	HP:0005623
HumanPheno	Severe generalized osteoporosis	COL1A1 COL1A2	3.58e-05	2	31	2	HP:0005897
HumanPheno	Femoral bowing present at birth, straightening with time	COL1A1 COL1A2	3.58e-05	2	31	2	HP:0005005
HumanPheno	Epiphyseal stippling	DDR2 DLK1 COL1A1 COL1A2	8.81e-05	40	31	4	HP:0010655
HumanPheno	Calcific stippling	DDR2 DLK1 COL1A1 COL1A2	9.72e-05	41	31	4	HP:0002832
HumanPheno	Popcorn calcification	COL1A1 COL1A2	1.07e-04	3	31	2	HP:6000871
HumanPheno	Bowing of limbs due to multiple fractures	COL1A1 COL1A2	2.13e-04	4	31	2	HP:0003023
HumanPheno	Undulate ribs	DLK1 TRPV6	2.13e-04	4	31	2	HP:0010561
HumanPheno	Subperiosteal bone formation	TRPV6 COL1A1	2.13e-04	4	31	2	HP:0031485
Domain	Defensin_propep	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	PF00879
Domain	Alpha-defensin	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	IPR006081
Domain	Defensin_1	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	PF00323
Domain	Alpha-defensin_pro	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	IPR016327
Domain	DEFENSIN	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	PS00269
Domain	Defensin_propep	DEFA1 DEFA3 DEFA4	1.62e-06	5	103	3	IPR002366
Domain	Defensin_beta/alpha	DEFA1 DEFA3 DEFA4	8.94e-06	8	103	3	IPR006080
Domain	DEFSN	DEFA1 DEFA3 DEFA4	8.94e-06	8	103	3	SM00048
Domain	REJ	PKD1L2 PKD1	1.79e-04	4	103	2	PS51111
Domain	REJ_dom	PKD1L2 PKD1	1.79e-04	4	103	2	IPR014010
Domain	-	PM20D1 CNDP1	2.98e-04	5	103	2	3.30.70.360
Domain	M20_dimer	PM20D1 CNDP1	2.98e-04	5	103	2	PF07687
Domain	Peptidase_M20_dimer	PM20D1 CNDP1	2.98e-04	5	103	2	IPR011650
Domain	Peptidase_M20	PM20D1 CNDP1	2.98e-04	5	103	2	PF01546
Domain	Peptidase_M20	PM20D1 CNDP1	2.98e-04	5	103	2	IPR002933
Domain	Choline_transpo	SLC44A2 SLC44A4	2.98e-04	5	103	2	PF04515
Domain	Choline_transptr-like	SLC44A2 SLC44A4	2.98e-04	5	103	2	IPR007603
Domain	Prot_inh_Kazal-m	SPINK2 SPINK9	2.98e-04	5	103	2	IPR001239
Domain	TAS2R	TAS2R42 TAS2R40 TAS2R39	3.86e-04	26	103	3	PF05296
Domain	T2R	TAS2R42 TAS2R40 TAS2R39	3.86e-04	26	103	3	IPR007960
Domain	PKD/REJ-like	PKD1L2 PKD1	4.45e-04	6	103	2	IPR002859
Domain	REJ	PKD1L2 PKD1	4.45e-04	6	103	2	PF02010
Domain	GPS	PKD1L2 CELSR1 PKD1	8.61e-04	34	103	3	SM00303
Domain	GPS	PKD1L2 CELSR1 PKD1	9.38e-04	35	103	3	PF01825
Domain	GPS	PKD1L2 CELSR1 PKD1	1.02e-03	36	103	3	PS50221
Domain	GPS	PKD1L2 CELSR1 PKD1	1.10e-03	37	103	3	IPR000203
Domain	Fib_collagen_C	COL1A1 COL1A2	1.60e-03	11	103	2	IPR000885
Domain	COLFI	COL1A1 COL1A2	1.60e-03	11	103	2	PF01410
Domain	PKD_channel	PKD1L2 PKD1	1.60e-03	11	103	2	PF08016
Domain	NC1_FIB	COL1A1 COL1A2	1.60e-03	11	103	2	PS51461
Domain	Fib_collagen_C	COL1A1 COL1A2	1.60e-03	11	103	2	PD002078
Domain	COLFI	COL1A1 COL1A2	1.60e-03	11	103	2	SM00038
Domain	PKD1_2_channel	PKD1L2 PKD1	1.60e-03	11	103	2	IPR013122
Domain	Chemokine_CXC	CXCL14 PF4V1	3.44e-03	16	103	2	IPR001089
Domain	SMALL_CYTOKINES_CXC	CXCL14 PF4V1	3.88e-03	17	103	2	PS00471
Domain	Aa_trans	SLC38A4 SLC38A2	3.88e-03	17	103	2	PF01490
Domain	AA_transpt_TM	SLC38A4 SLC38A2	3.88e-03	17	103	2	IPR013057
Domain	LH2	PKD1L2 PKD1	4.35e-03	18	103	2	SM00308
Domain	Cation_ATPase_N	ATP13A4 ATP2B4	4.35e-03	18	103	2	PF00690
Domain	Cation_ATPase_N	ATP13A4 ATP2B4	4.35e-03	18	103	2	SM00831
Domain	KAZAL_1	SPINK2 SPINK9	4.35e-03	18	103	2	PS00282
Domain	ATPase_P-typ_cation-transptr_N	ATP13A4 ATP2B4	4.84e-03	19	103	2	IPR004014
Domain	PLAT	PKD1L2 PKD1	5.91e-03	21	103	2	PS50095
Domain	-	PKD1L2 PKD1	5.91e-03	21	103	2	2.60.60.20
Domain	PLAT	PKD1L2 PKD1	5.91e-03	21	103	2	PF01477
Domain	PLAT/LH2_dom	PKD1L2 PKD1	5.91e-03	21	103	2	IPR001024
Pathway	REACTOME_DEFENSINS	DEFB104A DEFA1 DEFA3 DEFA4 DEFB109B	9.97e-06	53	77	5	M557
Pathway	REACTOME_ALPHA_DEFENSINS	DEFA1 DEFA3 DEFA4	1.83e-05	10	77	3	M26955
Pathway	REACTOME_ALPHA_DEFENSINS	DEFA1 DEFA3 DEFA4	2.51e-05	11	77	3	MM14569
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	HFE ATP13A4 SLC38A4 SLC44A2 SLC44A4 SLC38A2 NALCN ABCA6 TRPM3 SLC2A6 TRPV6 SLC24A1 ATP2B4	7.33e-05	681	77	13	MM14985
Pathway	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	ITGA1 COL1A1 COL1A2	8.34e-05	16	77	3	M9450
Pathway	REACTOME_DISEASES_OF_HEMOSTASIS	F12 COL1A1 COL1A2	1.43e-04	19	77	3	M48230
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	HFE ATP13A4 SLC38A4 SLC44A2 SLC44A4 SLC38A2 NALCN ABCA6 TRPM3 SLC2A6 TRPV6 SLC24A1 ATP2B4	1.60e-04	736	77	13	M27287
Pathway	REACTOME_ANTIMICROBIAL_PEPTIDES	DEFB104A DEFA1 DEFA3 DEFA4 DEFB109B	1.95e-04	98	77	5	M27627
Pathway	REACTOME_HEMOSTASIS	DOCK8 PF4V1 SIRPA ITGA1 IFNA2 F12 CD84 THPO PRCP ATP2B4 COL1A1 COL1A2	2.92e-04	679	77	12	M8395
Pathway	PID_LYMPH_ANGIOGENESIS_PATHWAY	ITGA1 COL1A1 COL1A2	3.31e-04	25	77	3	M274
Pathway	PID_INTEGRIN1_PATHWAY	ITGA1 TGFBI COL1A1 COL1A2	4.59e-04	66	77	4	M18
Pathway	WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY	F12 COL1A1 COL1A2	4.65e-04	28	77	3	M42541
Pathway	REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN	COL1A1 COL1A2	6.08e-04	7	77	2	M48265
Pathway	REACTOME_DEFENSINS	DEFA1 DEFA3 DEFA4	6.31e-04	31	77	3	MM14568
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	DDR2 COL1A1 COL1A2	6.93e-04	32	77	3	MM14924
Pathway	REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	COL1A1 COL1A2	8.07e-04	8	77	2	M48236
Pathway	BIOCARTA_EPHA4_PATHWAY	ITGA1 EPHB1	1.03e-03	9	77	2	MM1388
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS2R42 TAS2R40 TAS2R39	1.07e-03	37	77	3	MM15067
Pathway	REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS	TAS2R42 TAS2R40 TAS2R39	1.24e-03	39	77	3	M793
Pathway	REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	THPO COL1A1 COL1A2	1.24e-03	39	77	3	M10735
Pathway	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	PF4V1 F12 PRCP	1.24e-03	39	77	3	M2844
Pathway	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	PF4V1 F12 PRCP	1.24e-03	39	77	3	MM14559
Pathway	WP_OSTEOBLAST_SIGNALING	BGLAP COL1A1	1.29e-03	10	77	2	MM15862
Pathway	PID_INTEGRIN3_PATHWAY	TGFBI COL1A1 COL1A2	1.65e-03	43	77	3	M53
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	PF4V1 SIRPA CD84 COL1A1 COL1A2	1.71e-03	158	77	5	MM14812
Pathway	REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING	COL1A1 COL1A2	1.88e-03	12	77	2	MM15093
Pathway	REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING	COL1A1 COL1A2	1.88e-03	12	77	2	M27352
Pathway	REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN	COL1A1 COL1A2	1.88e-03	12	77	2	MM15452
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC38A4 SLC44A2 SLC44A4 SLC38A2 SLC2A6 SLC24A1	1.90e-03	238	77	6	MM15076
Pathway	REACTOME_GPCR_LIGAND_BINDING	HTR4 GPR37 TMIGD3 PF4V1 TAS2R42 TAS2R40 ACKR2 TAS2R39	2.35e-03	430	77	8	MM15160
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC38A4 SLC44A2 SLC44A4 SLC38A2 SLC2A6 SLC24A1	2.38e-03	249	77	6	M5988
Pubmed	DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.	CD52 CXCL14 PF4V1 DLK1 SIRPA LAPTM5 CD84 CD53	2.00e-08	145	109	8	21308776
Pubmed	Human α-defensin (DEFA) gene expression helps to characterise benign and malignant salivary gland tumours.	DEFA1 DEFA3 DEFA4	2.99e-08	3	109	3	23050799
Pubmed	Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.	DEFA1 DEFA3 DEFA4	2.99e-08	3	109	3	15620707
Pubmed	The osteocalcin and collagen type I (alpha 1) promoters share common basal regulatory units.	BGLAP COL1A1 COL1A2	1.20e-07	4	109	3	7598807
Pubmed	Cryptdin 3 forms anion selective channels in cytoplasmic membranes of human embryonic kidney cells.	DEFA1 DEFA3 DEFA4	1.20e-07	4	109	3	11960772
Pubmed	The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin.	TGFBI COL1A1 COL1A2	1.20e-07	4	109	3	12034705
Pubmed	Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta.	BGLAP COL1A1 COL1A2	1.20e-07	4	109	3	34893625
Pubmed	Genetic association analyses highlight biological pathways underlying mitral valve prolapse.	IGFBP5 COL1A1 COL1A2	2.98e-07	5	109	3	26301497
Pubmed	Increased gene copy number of DEFA1/DEFA3 worsens sepsis by inducing endothelial pyroptosis.	DEFA1 DEFA3 DEFA4	2.98e-07	5	109	3	30718392
Pubmed	Gp130-mediated signaling is necessary for normal osteoblastic function in vivo and in vitro.	BGLAP COL1A1 COL1A2	2.98e-07	5	109	3	14617570
Pubmed	LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine.	DLK1 DEFA3 DEFA4 IGFBP5	4.25e-07	20	109	4	19394326
Pubmed	Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	7927786
Pubmed	Development and regeneration of the neonatal digit tip in mice.	BGLAP COL1A1 COL1A2	5.95e-07	6	109	3	18234177
Pubmed	Structure and diversity of the murine cryptdin gene family.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	8188287
Pubmed	Strain-specific polymorphisms in Paneth cell α-defensins of C57BL/6 mice and evidence of vestigial myeloid α-defensin pseudogenes.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	21041494
Pubmed	Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	17132727
Pubmed	Antibacterial activity and specificity of the six human {alpha}-defensins.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	15616305
Pubmed	Enteric defensins: antibiotic peptide components of intestinal host defense.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	1500431
Pubmed	Activation of Paneth cell alpha-defensins in mouse small intestine.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	11733520
Pubmed	Cryptdins: antimicrobial defensins of the murine small intestine.	DEFA1 DEFA3 DEFA4	5.95e-07	6	109	3	1500163
Pubmed	Osteogenic and angiogenic profiles of the palatal process of the maxilla and the palatal process of the palatine bone.	BGLAP COL1A1 COL1A2	1.04e-06	7	109	3	34569061
Pubmed	A novel murine beta -defensin expressed in tongue, esophagus, and trachea.	DEFA1 DEFA3 DEFA4	1.04e-06	7	109	3	10922379
Pubmed	Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria.	DEFA1 DEFA3 DEFA4	1.04e-06	7	109	3	11248802
Pubmed	Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment.	BGLAP COL1A1 COL1A2	1.66e-06	8	109	3	15456762
Pubmed	Formation and maturation of the murine meniscus.	BGLAP COL1A1 COL1A2	1.66e-06	8	109	3	27664939
Pubmed	Type XIII collagen strongly affects bone formation in transgenic mice.	BGLAP COL1A1 COL1A2	1.66e-06	8	109	3	16007336
Pubmed	Isolation and characterization of a novel plasma membrane protein, osteoblast induction factor (obif), associated with osteoblast differentiation.	BGLAP COL1A1 COL1A2	1.66e-06	8	109	3	20025746
Pubmed	The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2).	CLEC4M CD84 LY9	1.66e-06	8	109	3	12621057
Pubmed	Molecular properties of wild-type and mutant betaIG-H3 proteins.	TGFBI COL1A1 COL1A2	1.66e-06	8	109	3	11867580
Pubmed	Gene polymorphisms, bone mineral density and bone mineral content in young children: the Iowa Bone Development Study.	BGLAP COL1A1 COL1A2	1.66e-06	8	109	3	12879219
Pubmed	Delayed osteoblastic differentiation and bone development in Cx43 knockout mice.	BGLAP COL1A1 COL1A2	2.48e-06	9	109	3	21934140
Pubmed	Neutral Sphingomyelinase 2 (SMPD3) Deficiency in Mice Causes Chondrodysplasia with Unimpaired Skeletal Mineralization.	BGLAP COL1A1 COL1A2	2.48e-06	9	109	3	31199918
Pubmed	Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium.	ITGA1 BGLAP COL1A1	2.48e-06	9	109	3	17050674
Pubmed	Genetic mapping of 40 cDNA clones on the mouse genome by PCR.	IFNA2 BGLAP DEFA1 DEFA3 DEFA4	3.04e-06	71	109	5	8043949
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	PKD1L2 TRPM3 PKD1 TRPV6	3.48e-06	33	109	4	19834762
Pubmed	Deletion of Tfam in Prx1-Cre expressing limb mesenchyme results in spontaneous bone fractures.	BGLAP COL1A1 COL1A2	3.54e-06	10	109	3	35947192
Pubmed	Ucma is not necessary for normal development of the mouse skeleton.	BGLAP COL1A1 COL1A2	3.54e-06	10	109	3	22155508
Pubmed	Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes.	DEFA1 DEFA3 DEFA4	4.85e-06	11	109	3	15494476
Pubmed	ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.	BGLAP COL1A1 COL1A2	6.45e-06	12	109	3	17141628
Pubmed	Copy number variation of defensin genes and HIV infection in Brazilian children.	DEFB104A DEFA3 DEFA4	8.37e-06	13	109	3	19194307
Pubmed	TGFbeta-mediated FGF signaling is crucial for regulating cranial neural crest cell proliferation during frontal bone development.	BGLAP COL1A1 COL1A2	8.37e-06	13	109	3	16368934
Pubmed	Overexpression of BMP3 in the developing skeleton alters endochondral bone formation resulting in spontaneous rib fractures.	BGLAP COL1A1 COL1A2	8.37e-06	13	109	3	19653325
Pubmed	Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.	BGLAP COL1A1 COL1A2	8.37e-06	13	109	3	26925839
Pubmed	Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro.	DEFA1 DEFA3	9.73e-06	2	109	2	12871849
Pubmed	[Phenotype-genotype analysis and detection of gene variant in six families with osteogenesis imperfecta].	COL1A1 COL1A2	9.73e-06	2	109	2	32335875
Pubmed	Molecular cloning, characterization, and chromosomal localization of the mouse homologue of CD84, a member of the CD2 family of cell surface molecules.	CD84 LY9	9.73e-06	2	109	2	10079287
Pubmed	Unequal Impact of COL1A1 and COL1A2 Variants on Dentinogenesis Imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	36951356
Pubmed	Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.	COL1A1 COL1A2	9.73e-06	2	109	2	17211858
Pubmed	Isolation and characterization of the cyanogen bromide peptides from the alpha 1 and alpha 2 chains of human skin collagen.	COL1A1 COL1A2	9.73e-06	2	109	2	5529814
Pubmed	Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations.	COL1A1 COL1A2	9.73e-06	2	109	2	9443882
Pubmed	Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.	COL1A1 COL1A2	9.73e-06	2	109	2	15241796
Pubmed	Human Neutrophil Peptides 1-3--early markers in development of colorectal adenomas and carcinomas.	DEFA1 DEFA3	9.73e-06	2	109	2	18957723
Pubmed	Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	24668929
Pubmed	[Relationship of collagen type I alpha 1 and alpha 2 gene polymorphisms with bone mineral density].	COL1A1 COL1A2	9.73e-06	2	109	2	16864092
Pubmed	Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis.	COL1A1 COL1A2	9.73e-06	2	109	2	1303238
Pubmed	Regional chromosome mapping of human collagen genes alpha 2(I) and alpha 1(I) (COLIA2 and COLIA1).	COL1A1 COL1A2	9.73e-06	2	109	2	3857213
Pubmed	Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.	COL1A1 COL1A2	9.73e-06	2	109	2	1874719
Pubmed	Differential unfolding of alpha1 and alpha2 chains in type I collagen and collagenolysis.	COL1A1 COL1A2	9.73e-06	2	109	2	18644377
Pubmed	COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	21344539
Pubmed	Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.	COL1A1 COL1A2	9.73e-06	2	109	2	31876392
Pubmed	Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta/Ehlers-Danlos Syndrome overlap syndrome.	COL1A1 COL1A2	9.73e-06	2	109	2	23692737
Pubmed	Clinical features, molecular results, and management of 12 individuals with the rare arthrochalasia Ehlers-Danlos syndrome.	COL1A1 COL1A2	9.73e-06	2	109	2	32091183
Pubmed	Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	11668615
Pubmed	Salivary levels of HNP 1-3 are related to oral ulcer activity in Behçet's disease.	DEFA1 DEFA3	9.73e-06	2	109	2	22861387
Pubmed	Gene expression patterns associated with infertility in humans and rodent models.	SPINK2 DLK1	9.73e-06	2	109	2	15120973
Pubmed	Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer.	BGLAP COL1A1	9.73e-06	2	109	2	17889845
Pubmed	Influence of type I collagen polymorphisms and risk of anterior cruciate ligament rupture in athletes: a case-control study.	COL1A1 COL1A2	9.73e-06	2	109	2	35172811
Pubmed	Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants.	COL1A1 COL1A2	9.73e-06	2	109	2	20721936
Pubmed	A cysteine-based molecular code informs collagen C-propeptide assembly.	COL1A1 COL1A2	9.73e-06	2	109	2	30310058
Pubmed	Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice.	COL1A1 COL1A2	9.73e-06	2	109	2	10608859
Pubmed	The significance of carboxy-terminal telopeptide of type I collagen (ICTP) and osteocalcin (OC) in assessment of bone disease in patients with multiple myeloma.	BGLAP COL1A1	9.73e-06	2	109	2	16263577
Pubmed	Defensins: antimicrobial and cytotoxic peptides of mammalian cells.	DEFA1 DEFA3	9.73e-06	2	109	2	8476558
Pubmed	Deposition of apatite in mineralizing vertebrate extracellular matrices: A model of possible nucleation sites on type I collagen.	COL1A1 COL1A2	9.73e-06	2	109	2	21405976
Pubmed	The human type I collagen mutation database.	COL1A1 COL1A2	9.73e-06	2	109	2	9016532
Pubmed	Mutations in type I collagen genes in Japanese osteogenesis imperfecta patients.	COL1A1 COL1A2	9.73e-06	2	109	2	17875077
Pubmed	Novel quantitative trait loci for central corneal thickness identified by candidate gene analysis of osteogenesis imperfecta genes.	COL1A1 COL1A2	9.73e-06	2	109	2	19714363
Pubmed	No association between polymorphisms and haplotypes of COL1A1 and COL1A2 genes and osteoporotic fracture in postmenopausal Chinese women.	COL1A1 COL1A2	9.73e-06	2	109	2	21602843
Pubmed	Age-related trends and reference intervals of cross-linked C-telopeptide of type I collagen and procollagen type I N-propeptide from a reference population of Sri Lankan adult women.	COL1A1 COL1A2	9.73e-06	2	109	2	34727246
Pubmed	Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer.	COL1A1 COL1A2	9.73e-06	2	109	2	27894325
Pubmed	Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.	COL1A1 COL1A2	9.73e-06	2	109	2	26927310
Pubmed	Effects of GABA on the expression of type I collagen gene in normal human dermal fibroblasts.	COL1A1 COL1A2	9.73e-06	2	109	2	27691923
Pubmed	Identification of COL1A1/2 Mutations and Fusions With Noncoding RNA Genes in Bizarre Parosteal Osteochondromatous Proliferation (Nora Lesion).	COL1A1 COL1A2	9.73e-06	2	109	2	36853784
Pubmed	Inter- and Intrafamilial Phenotypic Variability in Individuals with Collagen-Related Osteogenesis Imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	32166892
Pubmed	Comparing Clinical and Genetic Characteristics of De Novo and Inherited COL1A1/COL1A2 Variants in a Large Chinese Cohort of Osteogenesis Imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	35909573
Pubmed	Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	27519266
Pubmed	Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series.	DEFA1 DEFA3	9.73e-06	2	109	2	8080882
Pubmed	Mutation of the 5'-untranslated region stem-loop structure inhibits α1(I) collagen expression in vivo.	COL1A1 COL1A2	9.73e-06	2	109	2	21193410
Pubmed	COL1A1 and COL1A2 sequencing results in cohort of patients undergoing evaluation for potential child abuse.	COL1A1 COL1A2	9.73e-06	2	109	2	27090748
Pubmed	Assignment of the genes for mouse type I procollagen to chromosome 16 using mouse fibroblast-Chinese hamster somatic cell hybrids.	COL1A1 COL1A2	9.73e-06	2	109	2	6857446
Pubmed	Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia.	DEFA1 DEFA3	9.73e-06	2	109	2	19864642
Pubmed	Multidrug-resistant tuberculosis is associated with low plasma concentrations of human neutrophil peptides 1-3.	DEFA1 DEFA3	9.73e-06	2	109	2	21333105
Pubmed	Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	16705691
Pubmed	Four new cases of lethal osteogenesis imperfecta due to glycine substitutions in COL1A1 and genes. Mutations in brief no. 152. Online.	COL1A1 COL1A2	9.73e-06	2	109	2	10627137
Pubmed	Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease.	COL1A1 COL1A2	9.73e-06	2	109	2	22325288
Pubmed	Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta.	COL1A1 COL1A2	9.73e-06	2	109	2	27748872
Pubmed	The type I collagen pro alpha 1(I) COOH-terminal propeptide N-linked oligosaccharide. Functional analysis by site-directed mutagenesis.	COL1A1 COL1A2	9.73e-06	2	109	2	7629088
Pubmed	Alpha-defensin overexpression in patients with Bell's palsy and Ramsay Hunt syndrome.	DEFA1 DEFA3	9.73e-06	2	109	2	22737966
Pubmed	Midpregnancy vaginal fluid defensins, bacterial vaginosis, and risk of preterm delivery.	DEFA1 DEFA3	9.73e-06	2	109	2	18757648
Pubmed	Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix.	COL1A1 COL1A2	9.73e-06	2	109	2	7881420
Pubmed	Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.	BGLAP COL1A1	9.73e-06	2	109	2	17252541
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	DEFB104A DEFA1 DEFA3 DEFA4 DEFB109B	2.50e-04	234	109	5	chr8p23
Cytoband	8p23.1	DEFB104A DEFA1 DEFA3 DEFB109B	5.15e-04	154	109	4	8p23.1
GeneFamily	Solute carriers	SLC38A4 SLC22A23 SLC26A5 SLC44A2 SLC10A3 SLC44A4 SLC7A14 SLC38A2 SLC2A6 SLC24A1	8.32e-06	395	79	10	752
GeneFamily	Defensins, alpha	DEFA1 DEFA3 DEFA4	1.72e-05	12	79	3	502
GeneFamily	Taste 2 receptors	TAS2R42 TAS2R40 TAS2R39	6.55e-04	39	79	3	1162
GeneFamily	Serine peptidase inhibitors, Kazal type	SPINK2 SPINK9	8.29e-04	10	79	2	740
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	CD52 SIRPA ITGA1 CLEC4M CD84 CD53 LY9	1.67e-03	394	79	7	471
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL	SUSD4 DOCK8 SLC22A23 SIRPA ITGA1 LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1 EPHB1	4.00e-07	382	105	11	M45756
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL	DOCK8 SLC38A4 SLC22A23 SIRPA CELSR1 RNASE4 EFNA5 IGFBP5 ACKR2 SLC24A1 EPHB1	6.61e-07	402	105	11	M45754
Coexpression	TRAVAGLINI_LUNG_LYMPHATIC_CELL	SIRPA LAPTM5 TGFBI SLC38A2 EFNA5 IGFBP5 ACKR2 SLC24A1	2.05e-06	209	105	8	M41670
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	HFE CD52 DOCK8 DDX60 TMIGD3 SIRPA PKD1L2 LAPTM5 CD84 RNASE4 CD53 LY9	6.70e-06	615	105	12	MM3641
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN	HFE GIMAP4 TMEM53 SPINK2 SLC38A4 EFNA5 TRPM3	1.49e-05	197	105	7	M8025
Coexpression	SANSOM_APC_TARGETS_DN	GIMAP4 CD52 GBF1 DDR2 CXCL14 SIRPA LAPTM5 TGFBI CD53	1.69e-05	366	105	9	M1432
Coexpression	LEE_AGING_NEOCORTEX_DN	HTR4 IFNA2 BGLAP ASIP LY9	1.77e-05	80	105	5	MM646
Coexpression	MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN	ATP13A4 PF4V1 DLK1 TGFBI EFNA5 IGFBP5 ACKR2	3.39e-05	224	105	7	M38981
Coexpression	RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS	GIMAP4 CD52 LAPTM5 SLC38A2 CUTA PRF1 CD53	3.59e-05	226	105	7	M41749
Coexpression	KONDO_EZH2_TARGETS	SUSD4 TMEM116 RNASE4 IGFBP5 ACKR2 LY9 COL1A1	3.90e-05	229	105	7	M5301
Coexpression	MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	PF4V1 DLK1 TGFBI EFNA5 IGFBP5 ACKR2	4.45e-05	159	105	6	M38979
Coexpression	NABA_MATRISOME	ISM1 CXCL14 PF4V1 CLEC4M IFNA2 F12 BGLAP TGFBI OPTC THPO IGFBP5 SERPINA7 COL1A1 COL1A2	5.00e-05	1008	105	14	MM17056
Coexpression	KIM_GLIS2_TARGETS_UP	CXCL14 PF4V1 TGFBI COL1A1 COL1A2	5.74e-05	102	105	5	MM1064
Coexpression	NABA_MATRISOME	ISM1 CXCL14 PF4V1 CLEC4M IFNA2 F12 BGLAP TGFBI OPTC THPO IGFBP5 SERPINA7 COL1A1 COL1A2	6.05e-05	1026	105	14	M5889
Coexpression	DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS	SLC38A4 DLK1 F12 PRAP1 IGSF1 SERPINA7	1.12e-04	188	105	6	M40287
Coexpression	WILCOX_RESPONSE_TO_PROGESTERONE_DN	IGFBP5 ATP2B4 COL1A1 COL1A2	1.13e-04	62	105	4	M16774
Coexpression	CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE	CXCL14 DLK1 COL1A1 COL1A2	1.36e-04	65	105	4	M39309
Coexpression	GSE3982_NKCELL_VS_TH1_UP	TP53I11 XKR8 SLC10A3 ZNF34 EFNA5 EPHB1	1.37e-04	195	105	6	M5593
Coexpression	GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP	SLC10A3 CD84 DEFA4 ASIP ATP2B4 GPRC5B	1.41e-04	196	105	6	M8428
Coexpression	GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN	DDX60 SIRPA CD84 TGFBI SLC2A6 LY9	1.49e-04	198	105	6	M4603
Coexpression	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP	GIMAP4 CD52 XKR8 PRCP TAS2R40 ATP2B4	1.49e-04	198	105	6	M7944
Coexpression	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	TRHDE SLC38A4 VANGL2 ABCA6 CD53 FRMD5	1.53e-04	199	105	6	M8082
Coexpression	GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP	TP53I11 SLC10A3 ITGA1 LAPTM5 CD84 LY9	1.53e-04	199	105	6	M8380
Coexpression	GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP	ABHD14A SLC22A23 SLC44A2 SIRPA HUWE1 TGFBI	1.57e-04	200	105	6	M5097
Coexpression	PASTURAL_RIZ1_TARGETS_DN	DLK1 LAPTM5	1.58e-04	5	105	2	M4364
Coexpression	LEE_AGING_NEOCORTEX_DN	HTR4 BGLAP ASIP LY9	1.63e-04	68	105	4	M1497
Coexpression	MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN	ATP13A4 PF4V1 DLK1 TGFBI EFNA5 ACKR2	1.90e-04	207	105	6	M38977
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN	CELSR1 RNASE4 EFNA5 GPRC5B COL1A2	2.23e-04	136	105	5	M41157
Coexpression	VERHAAK_GLIOBLASTOMA_MESENCHYMAL	HFE SLC10A3 LAPTM5 TGFBI COL1A1 COL1A2	2.39e-04	216	105	6	M2122
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_500	TTC39B CD52 DDX60 DDR2 ITGA1 LAPTM5 RNASE4 EFNA5 IGFBP5 CD53 COL1A1 COL1A2	5.50e-07	408	101	12	gudmap_kidney_adult_RenalCapsule_500
CoexpressionAtlas	BM Top 100 - ovary	DLK1 RNASE4 IGFBP5 GREB1 COL1A1 COL1A2	1.02e-06	70	101	6	BM Top 100 - ovary
CoexpressionAtlas	liver	CYP2B6 SLC38A4 CLEC4M F12 RNASE4 THPO ABCA6 PRAP1 SERPINA7 CNDP1	3.12e-05	419	101	10	liver
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_500	DDX60 DDR2 ITGA1 IGFBP5	3.86e-05	40	101	4	gudmap_kidney_adult_Mesangium_Meis_k4_500
CoexpressionAtlas	Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4	DDR2 ISM1 CXCL14 DLK1 TGFBI RNASE4 IGFBP5 ABCA6 COL1A1 COL1A2	4.45e-05	437	101	10	GSM777046_500
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	ATP13A4 CD52 DOCK8 SLC38A4 DEFB104A CXCL14 RNF183 DLK1 PKD1L2 TRPM3 PROM2 TRPV6 GREB1 IGSF1 SHISA6	5.70e-05	976	101	15	PCBC_ECTO_blastocyst_1000
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	TTC39B CD52 DDX60 DDR2 SLC44A2 ITGA1 LAPTM5 RNASE4 EFNA5 IGFBP5 CD53 COL1A1 COL1A2	8.10e-05	778	101	13	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	ATP13A4 DOCK8 SLC38A4 DEFB104A CXCL14 RNF183 PKD1L2 TRPM3 TRPV6 SHISA6	1.09e-04	487	101	10	PCBC_ECTO_blastocyst_500
CoexpressionAtlas	PP_HSC_top-relative-expression-ranked_100	CD52 SPINK2 LAPTM5 CD84 CD53	1.16e-04	100	101	5	PP_HSC_100
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_1000	SUSD4 DOCK8 SLC38A4 PM20D1 CXCL14 VANGL2 CELSR1 PROM2 TRPV6 GREB1 FRMD5 GPRC5B CNDP1	1.26e-04	813	101	13	gudmap_developingKidney_e11.5_ureteric bud_1000
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500	CD52 DDR2 LAPTM5 RNASE4 EFNA5 COL1A1 COL1A2	1.51e-04	240	101	7	gudmap_kidney_adult_RenalCapsule_k1_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_500	HTR4 DOCK8 PM20D1 CXCL14	1.57e-04	57	101	4	gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_200	HTR4 PM20D1 PROM2	1.73e-04	23	101	3	gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k1
CoexpressionAtlas	alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3	GIMAP4 TTC39B DDX60 ITGA1 CD84 PRF1 LY9 ATP2B4	1.84e-04	331	101	8	GSM538329_500
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1	DDR2 GPR85 ITGA1 TGFBI RNASE4 IGFBP5 COL1A1 COL1A2	2.04e-04	336	101	8	ratio_EB_vs_SC_1000_K1
CoexpressionAtlas	Mesoderm Day 15-reprogram_NA_vs_Mesoderm Day 15-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05	ITGA1 SLC44A4 PRAP1 IGSF1 GNRH2 SERPINA7	2.16e-04	179	101	6	PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-OSK-L-l-p53KD_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 15-method_NA_vs_Mesoderm Day 15-method_episomal-Confounder_removed-fold2.0_adjp0.05	ITGA1 SLC44A4 PRAP1 IGSF1 GNRH2 SERPINA7	2.16e-04	179	101	6	PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-episomal_cfr-2X-p05
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	TTC39B CD52 SUSD4 SLC22A23 SLC26A5 TP53I11 DLK1 CELSR1 RNASE4 PROM2 ATP2B4 FRMD5 COL1A1 COL1A2	2.30e-04	984	101	14	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5	DDR2 TGFBI IGFBP5 COL1A1 COL1A2	2.33e-04	116	101	5	ratio_EB_vs_SC_500_K5
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_100	GPR37 DLK1 COL1A1	2.51e-04	26	101	3	gudmap_developingGonad_P2_testes_100_k2
CoexpressionAtlas	alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4	GIMAP4 TTC39B DDX60 ITGA1 CD84 PRF1 LY9 ATP2B4	2.68e-04	350	101	8	GSM538318_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4	GIMAP4 CD52 DDR2 SLC26A5 ITGA1 BGLAP LAPTM5 RNASE4 ATP2B4 COL1A1 COL1A2	2.84e-04	655	101	11	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_1000	GPR37 SLC38A4 PRCP COL1A1 EPHB1	3.17e-04	124	101	5	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k1
CoexpressionAtlas	JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1	TRHDE HFE DDX60 DDR2 ITGA1 TGFBI IGFBP5 COL1A1 COL1A2	3.71e-04	464	101	9	JC_fibro_1000_K1
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#2_top-relative-expression-ranked_200	GPR37 DLK1 COL1A1	3.86e-04	30	101	3	gudmap_developingGonad_e12.5_testes_k2_200
CoexpressionAtlas	FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1	TRHDE CD52 ITGA1 BGLAP RNASE4 ATP2B4 COL1A1 COL1A2	3.96e-04	371	101	8	Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000	SUSD4 HTR4 GPR85 PM20D1 CXCL14 HUWE1 CELSR1 IGFBP5 PROM2 GRAMD1C FRMD5 GPRC5B	4.15e-04	800	101	12	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	GBF1 SLC22A23 CXCL14 DLK1 SIRPA SLC44A4 TGFBI RNASE4 PRAP1 IGSF1 GNRH2 SERPINA7 COL1A1 COL1A2	4.39e-04	1049	101	14	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500	TTC39B SLC38A4 DDR2 GPR85 XKR8 IGFBP5	4.57e-04	206	101	6	gudmap_developingKidney_e15.5_Peripheral blastema_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#3_top-relative-expression-ranked_1000	GPR85 SLC7A14 LAPTM5 IGFBP5 NALCN GPRC5B	4.69e-04	207	101	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k3
CoexpressionAtlas	DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_100	ISM1 CXCL14 CELSR1 GREB1	4.76e-04	76	101	4	gudmap_developingKidney_e12.5_renal vesicle_100
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3	TRHDE SLC26A5 ITGA1 BGLAP RNASE4 ATP2B4 COL1A1 COL1A2	4.98e-04	384	101	8	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500	TRHDE GPR85 CXCL14 HUWE1 GPRC5B	5.01e-04	137	101	5	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#2_top-relative-expression-ranked_500	HFE GIMAP4 LAPTM5 CD53 EPHB1	5.35e-04	139	101	5	gudmap_developingKidney_e15.5_Podocyte cells_500_k2
CoexpressionAtlas	AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2	TRHDE DDR2 ISM1 CXCL14 DLK1 ITGA1 TGFBI CDH20 IGFBP5 TRPM3 GNRH2 COL1A1 COL1A2	5.70e-04	951	101	13	Arv_EB-LF_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500	TTC39B SUSD4 SLC22A23 SLC26A5 TP53I11 DLK1 CELSR1 PROM2 FRMD5	5.92e-04	495	101	9	Facebase_RNAseq_e10.5_Olfactory Pit_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_200	HTR4 PM20D1 PROM2	6.12e-04	35	101	3	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k2
CoexpressionAtlas	DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#1_top-relative-expression-ranked_1000	HFE GIMAP4 SIRPA LAPTM5 CD53 EPHB1	6.31e-04	219	101	6	gudmap_developingKidney_e15.5_Podocyte cells_1000_k1
CoexpressionAtlas	DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#5_top-relative-expression-ranked_1000	SUSD4 DOCK8 SLC38A4 PROM2 TRPV6 FRMD5 GPRC5B	6.52e-04	306	101	7	gudmap_developingKidney_e11.5_ureteric bud_1000_k5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000	TRHDE TTC39B CD52 SLC26A5 DLK1 ITGA1 BGLAP RNASE4 PRAP1 GREB1 ATP2B4 COL1A1 COL1A2	6.72e-04	968	101	13	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000
CoexpressionAtlas	Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2	ITGA1 IGFBP5 COL1A1 COL1A2	7.27e-04	85	101	4	GSM777067_100
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	TGFBI IGFBP5 COL1A1 COL1A2	7.59e-04	86	101	4	GSM777055_100
CoexpressionAtlas	AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000	TRHDE ISM1 CXCL14 DLK1 DEFA1 TGFBI DEFA4 CDH20 TRPM3 GNRH2 SHISA6 COL1A1 COL1A2	7.61e-04	981	101	13	Arv_EB-LF_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_reference_PulmonMicrovasc_top-relative-expression-ranked_1000	GIMAP4 SLC38A4 SLC22A23 SIRPA ITGA1 CLEC4M LAPTM5 NALCN ABCA6 DDX60L SLC24A1 GRAMD1C GPRC5B	7.61e-04	981	101	13	PCBC_ctl_PulmonMicrovasc_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	TTC39B TP53I11 DLK1 CELSR1	7.93e-04	87	101	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K2
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	ATP13A4 CD52 DOCK8 SLC38A4 DEFB104A CXCL14 DLK1 PKD1L2 CDH20 TRPM3 TRPV6 GREB1 IGSF1	8.35e-04	991	101	13	PCBC_ECTO_fibroblast_1000
CoexpressionAtlas	ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000	DDR2 GPR85 ISM1 CXCL14 DLK1 ITGA1 TGFBI RNASE4 CDH20 IGFBP5 GNRH2 COL1A1 COL1A2	8.59e-04	994	101	13	PCBC_ratio_EB_vs_SC_1000
CoexpressionAtlas	Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05	GPR37 CXCL14 IGFBP5 SERPINA7	8.64e-04	89	101	4	PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05
CoexpressionAtlas	Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05	GPR37 CXCL14 IGFBP5 SERPINA7	8.64e-04	89	101	4	PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500	TTC39B SLC38A4 DDR2 GPR85 XKR8 HUWE1 TGFBI IGFBP5	9.06e-04	421	101	8	gudmap_developingKidney_e15.5_Peripheral blastema_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_200	SPINK9 DLK1 NALCN COL1A1 CNDP1	9.28e-04	157	101	5	gudmap_developingGonad_P2_epididymis_200
CoexpressionAtlas	Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3	HFE SPINK2 SIRPA CD84 TGFBI ABCA6 PRCP SLC2A6	9.48e-04	424	101	8	GSM854294_500
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	HFE SPINK2 SIRPA CLEC4M TGFBI ABCA6 PRCP SLC2A6	9.77e-04	426	101	8	GSM605859_500
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#3_top-relative-expression-ranked_200	GIMAP4 EPHB1	9.83e-04	10	101	2	gudmap_developingKidney_e15.5_S-shaped body_200_k3
CoexpressionAtlas	DevelopingKidney_e12.5_renal vesicle_emap-27679_top-relative-expression-ranked_200	ISM1 CXCL14 CELSR1 GREB1 EPHB1	1.04e-03	161	101	5	gudmap_developingKidney_e12.5_renal vesicle_200
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#4_top-relative-expression-ranked_200	CXCL14 CELSR1 GREB1	1.05e-03	42	101	3	gudmap_developingKidney_e15.5_S-shaped body_200_k4
CoexpressionAtlas	DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_200	GIMAP4 CXCL14 CELSR1 GREB1 EPHB1	1.07e-03	162	101	5	gudmap_developingKidney_e15.5_S-shaped body_200
CoexpressionAtlas	geo_heart_top-relative-expression-ranked_1000_k-means-cluster#1	DPY19L2 LAPTM5 PRF1 CD53	1.10e-03	95	101	4	geo_heart_1000_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000	HTR4 DOCK8 SLC22A23 DDR2 PM20D1 CXCL14 ITGA1 OPTC PROM2 GPRC5B COL1A1	1.11e-03	772	101	11	gudmap_developingLowerUrinaryTract_P1_bladder_1000_J
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	SLC38A4 DLK1 TGFBI EFNA5 IGFBP5 ATP2B4 COL1A2	1.15e-03	337	101	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-mature_NK_T_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 CD52 DOCK8 LAPTM5 CD84 PRF1 CD53 LY9 SLC24A1	2.16e-10	159	109	9	32d4c9f7ba6a96ce8443396b80568b41cbfc4927
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 DDR2 ISM1 TGFBI EFNA5 IGFBP5 NALCN FRMD5 COL1A2	8.27e-10	185	109	9	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	control-Lymphoid-CTL\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GIMAP4 CD52 DOCK8 ITGA1 LAPTM5 CD84 PRF1 CD53 LY9	1.10e-09	191	109	9	8df23473e24cfa51c09986102ddd391ed0f0b9cc
ToppCell	control-Lymphoid\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GIMAP4 CD52 DOCK8 ITGA1 LAPTM5 CD84 PRF1 CD53 LY9	1.38e-09	196	109	9	8ed172bb3a95f09722476f0880ae246561777d98
ToppCell	NS-control-d_0-4-Lymphoid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GIMAP4 CD52 DOCK8 ITGA1 LAPTM5 CD84 PRF1 CD53 LY9	1.44e-09	197	109	9	bd3f2d68eb108fe31e217c9124183920e7c82582
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	HTR4 DDR2 ISM1 ITGA1 TGFBI IGFBP5 NALCN COL1A1 COL1A2	1.64e-09	200	109	9	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 TTC39B CD52 LAPTM5 CD84 PRF1 CD53 LY9	4.92e-09	156	109	8	39aa3adbee9f04cdc0055487d393edfa515e062b
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 TTC39B CD52 LAPTM5 CD84 PRF1 CD53 LY9	4.92e-09	156	109	8	a09e3aefe78d63ad5428ad48c6f83e547eb819f6
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SUSD4 TP53I11 SIRPA CELSR1 RNASE4 EFNA5 ATP2B4 GPRC5B	1.33e-08	177	109	8	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SUSD4 TP53I11 SIRPA CELSR1 RNASE4 EFNA5 ATP2B4 GPRC5B	1.33e-08	177	109	8	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 TGFBI EFNA5 IGFBP5 NALCN COL1A1 COL1A2	1.45e-08	179	109	8	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DDR2 CXCL14 PF4V1 TGFBI ABCA6 GREB1 COL1A1 COL1A2	1.51e-08	180	109	8	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HTR4 ITGA1 RNASE4 IGFBP5 NALCN ABCA6 COL1A1 COL1A2	1.58e-08	181	109	8	9c157de9d3403e092c907599f2a2c16db5b21131
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD52 SPINK2 DOCK8 LAPTM5 CD84 PRF1 CD53 LY9	1.58e-08	181	109	8	1110a0375189c034e6b02e6ebceb7084e4590114
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HTR4 ITGA1 RNASE4 IGFBP5 NALCN ABCA6 COL1A1 COL1A2	1.58e-08	181	109	8	eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HTR4 ITGA1 RNASE4 IGFBP5 NALCN ABCA6 COL1A1 COL1A2	1.72e-08	183	109	8	bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 DDR2 ISM1 ITGA1 TGFBI NALCN COL1A1 COL1A2	1.72e-08	183	109	8	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 DDR2 ISM1 TGFBI EFNA5 IGFBP5 NALCN COL1A2	1.87e-08	185	109	8	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Endoth-Lymph\|World / shred by cell class for parenchyma	GIMAP4 SLC38A4 SIRPA LAPTM5 EFNA5 ACKR2 SLC24A1 GPRC5B	1.87e-08	185	109	8	97a6c4cd00684d4085d36ef32f7dbb99563ed357
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR2 CXCL14 RNASE4 IGFBP5 ABCA6 GREB1 COL1A1 COL1A2	2.12e-08	188	109	8	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 EFNA5 IGFBP5 TRPV6 ATP2B4 GPRC5B EPHB1	2.30e-08	190	109	8	e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 EFNA5 IGFBP5 TRPV6 ATP2B4 GPRC5B EPHB1	2.30e-08	190	109	8	f32d66c0e74e0a2a23ecb857c4daf0d8573a806c
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 EFNA5 IGFBP5 TRPV6 ATP2B4 GPRC5B EPHB1	2.30e-08	190	109	8	b79ffd05806244a9790cd04c66fb4f92c824e69f
ToppCell	NS-control-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GIMAP4 CD52 ITGA1 LAPTM5 CD84 PRF1 CD53 LY9	2.40e-08	191	109	8	27f2151da2f41015a979499f274ab1284a36189f
ToppCell	Endothelial_cells-Endothelial-B\|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id	SLC22A23 SIRPA LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1 GPRC5B	2.93e-08	196	109	8	36f95f9ef74eb951e41ef46fd136ceaef45208fc
ToppCell	tumor_Lung-Endothelial_cells-Lymphatic_ECs\|Endothelial_cells / Location, Cell class and cell subclass	SLC22A23 SIRPA LAPTM5 SLC38A2 EFNA5 ACKR2 SLC24A1 EPHB1	3.05e-08	197	109	8	a05237ee6d31d9eab491dd7007859d6285cf1424
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Mesothelial-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	DDR2 CXCL14 PF4V1 DEFA3 DEFA4 IGFBP5 COL1A1 COL1A2	3.43e-08	200	109	8	b33901d91b3af5c0cf310eede30ce03af90c9783
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	HTR4 GPR37 DDR2 ITGA1 TGFBI IGFBP5 NALCN COL1A2	3.43e-08	200	109	8	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDR2 CXCL14 PF4V1 DEFA3 DEFA4 IGFBP5 COL1A1 COL1A2	3.43e-08	200	109	8	23bc13983f6bdf95e63109b8bc14c4921ca85c3a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Mesothelial-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDR2 CXCL14 PF4V1 DEFA3 DEFA4 IGFBP5 COL1A1 COL1A2	3.43e-08	200	109	8	d276062545ecc428a28b12a74f06f3c6bbcff4a3
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD52 DDX60 SIRPA LAPTM5 CD84 RNASE4 CD53	1.39e-07	160	109	7	18954241e11309ecb0f3ca87897eadcb20dc8eca
ToppCell	facs-SCAT-Fat-3m-Myeloid-myeloid_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	1.78e-07	166	109	7	8395c74db8e4e54af97a3f2b75cb75171140ec31
ToppCell	facs-SCAT-Fat-3m-Myeloid\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	1.78e-07	166	109	7	76807edc5620514b53a14be354b84c54c112b8f9
ToppCell	facs-SCAT-Fat-3m-Myeloid-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	1.78e-07	166	109	7	645b842b94b8d2f4b26c2623f8589f56bd782c26
ToppCell	droplet-Heart-nan-18m-Hematologic-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 SIRPA LAPTM5 CD84 TGFBI CD53	2.09e-07	170	109	7	7077eaf68ac859f63d6581d26a95c20d6a04bd28
ToppCell	facs-GAT-Fat-3m-Myeloid-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	2.18e-07	171	109	7	3f796d53d3110e5d6e97de53bb49d323944659d6
ToppCell	facs-GAT-Fat-3m-Myeloid-myeloid_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	2.18e-07	171	109	7	d9fbc2b00dbf9dddc95d9a20d804459a9ebd1820
ToppCell	facs-GAT-Fat-3m-Myeloid\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 DOCK8 LAPTM5 CD84 TGFBI PRCP CD53	2.18e-07	171	109	7	e77bfc925d73ccffe3c8cfb13764e70579a7f942
ToppCell	facs-Lung-18m-Hematologic-myeloid\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD52 DOCK8 SIRPA LAPTM5 TGFBI SLC2A6 CD53	2.18e-07	171	109	7	4ad28ecfde3d529a09b80be908c446bd5274518e
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRHDE GIMAP4 CD52 LAPTM5 PRF1 CD53 LY9	2.18e-07	171	109	7	801893c318f7b1abc8d97bac86a00974f910a71c
ToppCell	facs-Lung-nan-3m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE GIMAP4 CD52 LAPTM5 CD84 PRF1 CD53	2.27e-07	172	109	7	7af0713c40ea48f1e92c859c4fc4d8f0137c4415
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 SIRPA LAPTM5 CD84 TGFBI SLC2A6 CD53	2.27e-07	172	109	7	0457ccc18697aaec44b7c30ae157aae8f48d8785
ToppCell	E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD52 DDX60 SIRPA LAPTM5 CD84 RNASE4 CD53	2.27e-07	172	109	7	714172f31abd0d25261df6115ec6a9df491fa14b
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 CD52 LAPTM5 CD84 PRF1 CD53 LY9	2.45e-07	174	109	7	986e591d3d46009e53548dfa1f2126cf31063ef4
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 CD52 LAPTM5 CD84 PRF1 CD53 LY9	2.45e-07	174	109	7	785be49a2dbbb1dff0fbced1b48b942c2f4a508d
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GIMAP4 CD52 LAPTM5 CELSR1 PRF1 CD53 LY9	2.45e-07	174	109	7	7c8cc5c2872fc7bcca7ebddaf5a6f20e617a2674
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ISM1 ITGA1 SLC38A2 IGFBP5 NALCN COL1A1 COL1A2	2.55e-07	175	109	7	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-pDC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD52 DOCK8 LAPTM5 ASIP CD53 LY9 EPHB1	2.86e-07	178	109	7	b7d1d8f76c1c2467b1a39a9b4150ed4a47144a15
ToppCell	T_cells-GZMK+_CD8+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	GIMAP4 TTC39B TP53I11 ITGA1 CD84 SLC2A6 LY9	2.97e-07	179	109	7	798f208014f2229c597934775646ddbbacf94b69
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPINK2 RNASE4 EFNA5 IGFBP5 COL1A1 COL1A2 EPHB1	3.20e-07	181	109	7	330d4322f4c4373f706273c1f4e218b59051b7fd
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DDR2 ISM1 CXCL14 ITGA1 TGFBI IGFBP5 NALCN	3.20e-07	181	109	7	d7e04e0ca549eac6d9b1192b6578f9b54943d54f
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPINK2 RNASE4 EFNA5 IGFBP5 COL1A1 COL1A2 EPHB1	3.20e-07	181	109	7	3f4d5d79c1286614514b0e8134079d6128a2a23e
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 RNASE4 EFNA5 ATP2B4 GPRC5B EPHB1	3.32e-07	182	109	7	2cc434e46985c66fc36de05344a67aa96d90abc9
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 RNASE4 EFNA5 ATP2B4 GPRC5B EPHB1	3.32e-07	182	109	7	0cde2775bdaaa2172499925bd59b0ac2d545eb27
ToppCell	facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SUSD4 CELSR1 RNASE4 EFNA5 ATP2B4 GPRC5B EPHB1	3.32e-07	182	109	7	3e7457b2a70b45735fb75d6617b7f34cef28758e
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 CD52 DOCK8 LAPTM5 CD84 CD53 LY9	3.58e-07	184	109	7	8fa7aa2a954f66576ada56670b4e1bb122864761
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GIMAP4 CD52 DOCK8 LAPTM5 CD84 CD53 LY9	3.58e-07	184	109	7	b5fbfcf8516c2dc20dffc36803692505a63f1297
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	DDR2 ISM1 IGFBP5 ABCA6 GREB1 COL1A1 COL1A2	3.71e-07	185	109	7	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 ITGA1 IGFBP5 NALCN COL1A1 COL1A2	3.71e-07	185	109	7	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 ITGA1 IGFBP5 NALCN COL1A1 COL1A2	3.85e-07	186	109	7	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GIMAP4 SLC26A5 CLEC4M EFNA5 ACKR2 SLC24A1 GPRC5B	3.85e-07	186	109	7	30dd4164c101006c8d95922d89652b82dbe4b5ea
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CXCL14 DLK1 IGFBP5 ABCA6 GREB1 COL1A1 COL1A2	3.85e-07	186	109	7	07d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 EFNA5 IGFBP5 NALCN COL1A1 COL1A2	4.14e-07	188	109	7	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 EFNA5 IGFBP5 NALCN COL1A1 COL1A2	4.14e-07	188	109	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SUSD4 CELSR1 IGFBP5 TRPV6 ATP2B4 GPRC5B EPHB1	4.14e-07	188	109	7	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SUSD4 CELSR1 IGFBP5 TRPV6 ATP2B4 GPRC5B EPHB1	4.14e-07	188	109	7	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR2 CXCL14 DLK1 RNASE4 NALCN ABCA6 COL1A1	4.29e-07	189	109	7	544d95df910f1b276995624509a7e41b219baca0
ToppCell	MatrixFB-Fibroblast-C\|MatrixFB / shred on cell class and cell subclass (v4)	CXCL14 DLK1 RNASE4 IGFBP5 PRCP COL1A1 COL1A2	4.44e-07	190	109	7	d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SUSD4 SLC38A4 SIRPA CLEC4M EFNA5 ABCA6 SLC24A1	4.44e-07	190	109	7	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	PSB-critical-LOC-Lymphoid-NK\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GIMAP4 CD52 DOCK8 ITGA1 PRF1 CD53 LY9	4.44e-07	190	109	7	e1b5d76edd4c1b95c0a7b94284a65043ab895e67
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 ISM1 ITGA1 IGFBP5 NALCN COL1A1 COL1A2	4.60e-07	191	109	7	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SPINK2 DOCK8 LAPTM5 CD84 DEFA4 CD53 LY9	4.60e-07	191	109	7	47f20686001f945bc31d5a0b974958e4009edb34
ToppCell	ASK454-Mesenchymal\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SLC38A4 DDR2 ITGA1 IGFBP5 ABCA6 COL1A1 COL1A2	4.60e-07	191	109	7	e30ae7a12439f8a79820b13f03e822c1223fd0cb
ToppCell	facs-Lung-3m-Mesenchymal-myofibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDR2 ISM1 TGFBI IGFBP5 ATP2B4 COL1A1 COL1A2	4.60e-07	191	109	7	fd8331c7abdd999f55ba43d307945c6abfccbf84
ToppCell	ASK454-Mesenchymal-Fibroblast\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	SLC38A4 DDR2 ITGA1 IGFBP5 ABCA6 COL1A1 COL1A2	4.60e-07	191	109	7	1726add3f392a061536b7aff72ba84303f4a0b1f
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CD52 SPINK2 DOCK8 LAPTM5 CD84 CD53 LY9	4.60e-07	191	109	7	14b11244c330cc4fe897253aaaf0df80caa01a55
ToppCell	PCW_07-8.5-Immune_Lymphocytic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD52 SPINK2 DOCK8 LAPTM5 PRF1 CD53 LY9	4.60e-07	191	109	7	8911b88f70e5deed027177be2e6745b80308616b
ToppCell	Nasal_Brush-Immune-Neutrophils\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	GIMAP4 CD52 DOCK8 SIRPA CD84 TGFBI CD53	4.77e-07	192	109	7	20a7f7beb01df1c4f915ec2f9b5a9dbcab157187
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLC38A4 SLC22A23 LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1	4.77e-07	192	109	7	5e709c0714e8eba27e03a6def0544256bedb3ced
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLC38A4 SIRPA LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1	4.77e-07	192	109	7	b016e229300c183e14c0e2bba494bf49c7899112
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HTR4 DDR2 ISM1 ITGA1 IGFBP5 COL1A1 COL1A2	4.77e-07	192	109	7	992d08092edbc68c47b945deb8708379738c239a
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLC38A4 SIRPA LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1	4.77e-07	192	109	7	ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell	367C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLC38A4 SLC22A23 LAPTM5 EFNA5 IGFBP5 ACKR2 SLC24A1	4.77e-07	192	109	7	5f4f44f15d3a2846981e68296643a4634930a211
ToppCell	droplet-Kidney-nan-18m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DEFB104A DDR2 CXCL14 RNASE4 ABCA6 COL1A1 COL1A2	4.77e-07	192	109	7	84149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCell	NS-control-d_0-4-Lymphoid-Treg\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GIMAP4 CD52 ITGA1 LAPTM5 CD84 CD53 LY9	4.77e-07	192	109	7	ef252dd9df161f665f53c047c0514381f80d6683
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD52 SPINK2 DOCK8 LAPTM5 PRF1 CD53 LY9	4.77e-07	192	109	7	6eadf0f37beae22838e930ad897a9b89e5e12cdb
ToppCell	facs-Lung-EPCAM-18m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD52 ISM1 CXCL14 LAPTM5 RNASE4 CD53 COL1A2	4.94e-07	193	109	7	b9ac74357435f2f24aaede62b2a1d31b5d96a12c
ToppCell	tumor_Lung-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	CD52 DOCK8 LAPTM5 CD84 PRF1 CD53 LY9	4.94e-07	193	109	7	8cc7172c327a9cf6823e1a35322a4e5960826ec8
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DDR2 ITGA1 TGFBI OPTC ATP2B4 COL1A1 COL1A2	4.94e-07	193	109	7	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDR2 ISM1 CXCL14 RNASE4 EFNA5 COL1A1 COL1A2	4.94e-07	193	109	7	fe9720185929ef849edd1b8eb4854306b392e5a2
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	DDR2 ISM1 ITGA1 NALCN ABCA6 COL1A1 COL1A2	4.94e-07	193	109	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC26A5 CLEC4M EFNA5 NALCN ACKR2 SLC24A1 GPRC5B	4.94e-07	193	109	7	bd0027fa97de41ae22ff64a61c8e217496f122ca
ToppCell	T_cell\|World / shred by cell class for nasal brushing	GIMAP4 CD52 ITGA1 LAPTM5 PRF1 CD53 LY9	4.94e-07	193	109	7	07530bbeffd5951880ed6ea50a962c102b05ccc2
ToppCell	NS-moderate-d_07-13-Lymphoid-Treg\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GIMAP4 ABHD14A CD52 ITGA1 PRF1 CD53 LY9	4.94e-07	193	109	7	6115d43017070a78d335687bd039c08f00f77029
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	DDR2 CXCL14 TGFBI TRPM3 PRAP1 COL1A1 COL1A2	5.11e-07	194	109	7	638b9fdce64ed00243b5303800ec66207d5fd640
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	DDR2 CXCL14 TGFBI TRPM3 PRAP1 COL1A1 COL1A2	5.11e-07	194	109	7	e9868c22934b6c0ac35e3e8270ec0b671bc6582a
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GIMAP4 CD52 SPINK2 DOCK8 LAPTM5 PRF1 CD53	5.11e-07	194	109	7	6385cf2a1529d2e225e407c33da959fccaaca3a4
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR2 CXCL14 IGFBP5 ABCA6 GREB1 COL1A1 COL1A2	5.11e-07	194	109	7	35b30bc954750e939f81a9a7498b8bc2ce69a299
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR2 ISM1 CXCL14 PKD1 GREB1 COL1A1 COL1A2	5.11e-07	194	109	7	ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 ITGA1 TGFBI IGFBP5 ABCA6 COL1A1 COL1A2	5.11e-07	194	109	7	240d122dcb9dd1ab2867503ad85869853adcacae
Computational	Heart genes.	CD52 GBF1 HTR4 TP53I11 DLK1 DEFA3 TGFBI PRF1 PKD1 ACKR2 COL1A2	1.85e-05	423	60	11	MODULE_60
Computational	Fetal liver genes - metabolism and xenobiotics.	CYP2B6 HTR4 DLK1 F12 LAPTM5 DEFA3 TGFBI RNASE4 IGSF1 COL1A1 COL1A2	3.48e-05	453	60	11	MODULE_24
Computational	Heart, liver, kidney and pancreas metabolic and xenobiotic response genes.	CYP2B6 HTR4 DLK1 F12 LAPTM5 DEFA3 TGFBI RNASE4 PRF1 ASIP IGSF1 GPRC5B COL1A1 COL1A2	1.55e-04	835	60	14	MODULE_88
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TGFBI IGFBP5 COL1A1 COL1A2	1.67e-04	50	60	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	CXCL14 IGFBP5 COL1A1 COL1A2	1.67e-04	50	60	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1
Computational	Genes in the cancer module 55.	CYP2B6 HTR4 DLK1 F12 LAPTM5 DEFA3 TGFBI RNASE4 PRF1 ASIP IGSF1 COL1A1 COL1A2	5.53e-04	832	60	13	MODULE_55
Computational	Immune (humoral) and inflammatory response.	GIMAP4 CD52 HTR4 DEFB104A LAPTM5 DEFA3 TGFBI PRF1 CD53 COL1A2	7.98e-04	546	60	10	MODULE_84
Drug	AC1MO44M	DEFB104A CXCL14 SIRPA DEFA1 DEFA3 DEFA4 ACKR2	7.14e-08	77	106	7	CID003363163
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A	CD52 DDX60 IFNA2 DEFA4 IGFBP5 CD53 SLC24A1 SERPINA7 COL1A1	3.61e-07	197	106	9	5246_UP
Drug	4-carbethoxyhexafluorobutyryl chloride	DEFA1 DEFA3 ACKR2	9.74e-07	5	106	3	CID000161251
Drug	PFPA	DEFA1 DEFA3 PRF1 ACKR2	1.29e-06	18	106	4	CID000067742
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A	HFE HTR4 GPR37 DDX60 IGFBP5 CD53 LY9 COL1A1	3.55e-06	194	106	8	5699_UP
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A	HFE CYP2B6 TP53I11 HUWE1 THPO TRPM3 GNRH2 EPHB1	4.45e-06	200	106	8	4006_UP
Drug	AC1NRBPT	BGLAP TGFBI IGFBP5 PKD1 GNRH2 COL1A1 COL1A2	1.09e-05	162	106	7	CID005288571
Drug	AC1Q4I4X	DEFA1 DEFA3 ACKR2	1.15e-05	10	106	3	CID000122085
Drug	2-methoxyethoxy)acetic acid	DEFA1 DEFA3	2.15e-05	2	106	2	CID000027642
Drug	1,2,5,6-tetramethylnaphthalene	DEFA1 DEFA3	2.15e-05	2	106	2	CID006427081
Drug	1,4,5-trimethylnaphthalene	DEFA1 DEFA3	2.15e-05	2	106	2	CID000016478
Drug	p-sulfobenzyl alcohol	DEFA1 DEFA3	2.15e-05	2	106	2	CID000441138
Drug	5'-methylthioadenosine	COL1A1 COL1A2	2.15e-05	2	106	2	ctd:C008500
Drug	MK-677	DLK1 BGLAP IGFBP5 GNRH2 COL1A1	2.32e-05	73	106	5	CID000178024
Drug	pyrachlostrobin	DDR2 PM20D1 SLC10A3 DLK1 ITGA1 LAPTM5 CD84 CELSR1 RNASE4 IGFBP5 SLC2A6 CD53 TRPV6 COL1A1	2.40e-05	811	106	14	ctd:C513428
Drug	T-E-A-T	DLK1 BGLAP IGFBP5 GNRH2 COL1A1	2.83e-05	76	106	5	CID000086807
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	HFE TP53I11 HUWE1 RNASE4 IGFBP5 SLC2A6 COL1A1	2.96e-05	189	106	7	6003_UP
Drug	denatonium	BGLAP OPTC COL1A1	3.44e-05	14	106	3	CID000019518
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	HFE CD52 TP53I11 HUWE1 CLEC4M IGFBP5 EPHB1	3.50e-05	194	106	7	5610_UP
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A	HFE HTR4 HUWE1 CLEC4M THPO IGFBP5 TRPM3	3.86e-05	197	106	7	2556_UP
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A	HFE GPR37 CD84 IGFBP5 SLC24A1 ATP2B4 COL1A1	3.86e-05	197	106	7	1491_UP
Drug	Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A	HFE TMEM53 SPINK2 GPR85 IFNA2 ACKR2 SLC24A1	3.99e-05	198	106	7	5746_UP
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A	HFE SPINK2 GPR85 TP53I11 IFNA2 IGFBP5 COL1A2	3.99e-05	198	106	7	5867_UP
Drug	Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	HTR4 TP53I11 DEFA4 IGFBP5 CD53 IGSF1 COL1A1	3.99e-05	198	106	7	5500_UP
Drug	H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A	HFE GPR85 TP53I11 IFNA2 LAPTM5 TGFBI PRF1	4.12e-05	199	106	7	5968_UP
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; MCF7; HT_HG-U133A	CD52 SPINK2 TRPM3 GRAMD1C ATP2B4 COL1A1 EPHB1	4.25e-05	200	106	7	5513_UP
Drug	LY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A	CYP2B6 HTR4 HUWE1 CD84 EFNA5 CD53 COL1A1	4.25e-05	200	106	7	4440_UP
Drug	Tc-99m HMDP	HFE BGLAP	6.42e-05	3	106	2	CID000123801
Drug	4-ethylbenzoate	DEFA1 DEFA3	6.42e-05	3	106	2	CID000012086
Drug	neoeriocitrin	BGLAP COL1A1	6.42e-05	3	106	2	ctd:C553460
Drug	Bac7	DEFB104A DEFA1 DEFA3 DEFA4	6.79e-05	47	106	4	CID000163998
Drug	GHRP-6	DLK1 BGLAP IGFBP5 GNRH2 COL1A1	8.69e-05	96	106	5	CID004345065
Drug	AC1Q5HK6	CYP2B6 HTR4 PF4V1 BGLAP TGFBI DEFA4 IGFBP5 GNRH2 COL1A1 COL1A2	1.17e-04	501	106	10	CID000003640
Drug	ticlopidine	CYP2B6 PF4V1 THPO COL1A1 COL1A2	1.21e-04	103	106	5	CID000005472
Drug	trifluoroacetamide	DEFA1 DEFA3 ACKR2	1.23e-04	21	106	3	CID000067717
Drug	O-C-O	BGLAP EFNA5 GNRH2 COL1A1 COL1A2	1.27e-04	104	106	5	CID000014785
Drug	Collagenase	COL1A1 COL1A2	1.28e-04	4	106	2	DB00048
Drug	topanol A	DEFA1 DEFA3	1.28e-04	4	106	2	CID000015884
Drug	4-fluorobenzoyl chloride	DEFA1 DEFA3	1.28e-04	4	106	2	CID000067879
Drug	AC1L3OZP	DEFA1 DEFA3	1.28e-04	4	106	2	CID000092862
Drug	sperabillin A	DEFA1 DEFA3	1.28e-04	4	106	2	CID006441177
Drug	xenognosin B	DEFA1 DEFA3	1.28e-04	4	106	2	CID005280551
Drug	oleth-3-phosphate	CD52 SIRPA CD53 ATP2B4	1.77e-04	60	106	4	CID000021452
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	HFE DDX60 IGFBP5 SLC2A6 PRF1 COL1A1	2.05e-04	181	106	6	2785_UP
Drug	AC1O5T5C	DEFA1 DEFA3	2.13e-04	5	106	2	CID006440182
Drug	dipropylacetal	DEFA1 DEFA3	2.13e-04	5	106	2	CID000066929
Drug	1kwq	DLK1 EFNA5 TRPV6	2.36e-04	26	106	3	CID003092847
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	GPR85 RNASE4 TRPM3 CD53 COL1A1 COL1A2	2.38e-04	186	106	6	5597_UP
Drug	Levonordefrin [829-74-3]; Up 200; 21.8uM; PC3; HT_HG-U133A	HFE CYP2B6 HTR4 GPR85 ITGA1 CD53	2.45e-04	187	106	6	5854_UP
Drug	Flavonoids	CYP2B6 SLC38A4 SLC26A5 DLK1 BGLAP LAPTM5 SLC38A2 THPO IGFBP5 GUCY2C PKD1 TRPV6 SLC24A1 ATP2B4 COL1A2	2.46e-04	1136	106	15	ctd:D005419
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A	HFE CD52 HTR4 IGFBP5 TRPM3 SLC2A6	2.52e-04	188	106	6	4386_UP
Drug	1 2M	HUWE1 IGFBP5 EPHB1	2.64e-04	27	106	3	CID005225083
Drug	Dicumarol [66-76-2]; Up 200; 11.8uM; HL60; HT_HG-U133A	HFE CD52 TP53I11 RNASE4 IGFBP5 GNRH2	2.82e-04	192	106	6	2561_UP
Drug	rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	HFE CD52 HUWE1 GREB1 GRAMD1C COL1A1	2.90e-04	193	106	6	921_UP
Drug	Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A	DDX60 CLEC4M CD84 RNASE4 TRPM3 GREB1	2.90e-04	193	106	6	5437_UP
Drug	NSC19448	BGLAP TGFBI EFNA5 GREB1 GNRH2 COL1A1 COL1A2	2.93e-04	273	106	7	CID000003054
Drug	BM-11	DEFA1 DEFA3 DEFA4	2.95e-04	28	106	3	CID003036083
Drug	Iopromide [73334-07-3]; Up 200; 5uM; MCF7; HT_HG-U133A	HFE TP53I11 IGFBP5 ACKR2 GREB1 SLC24A1	2.98e-04	194	106	6	3481_UP
Drug	Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A	HFE DDR2 HUWE1 ZNF34 EFNA5 COL1A2	2.98e-04	194	106	6	2998_UP
Drug	Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A	HFE CD52 TP53I11 F12 SLC24A1 COL1A1	2.98e-04	194	106	6	4744_UP
Drug	Meropenem [96036-03-2]; Up 200; 10.4uM; PC3; HT_HG-U133A	HFE TMEM53 DDX60 TP53I11 ITGA1 COL1A1	2.98e-04	194	106	6	5824_UP
Drug	butein; Down 200; 10uM; PC3; HG-U133A	TRHDE HFE CYP2B6 GPR37 TRPM3 PRF1	2.98e-04	194	106	6	582_DN
Drug	Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A	HFE HTR4 DDX60 GREB1 SLC24A1 COL1A1	2.98e-04	194	106	6	3846_UP
Drug	LY-171,883; Down 200; 1uM; MCF7; HG-U133A	HFE HTR4 TP53I11 IGFBP5 TRPM3 ASIP	2.98e-04	194	106	6	222_DN
Drug	Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; PC3; HG-U133A	TRHDE HFE HTR4 DDX60 TGFBI CD53	3.06e-04	195	106	6	1898_UP
Drug	Procarbazine hydrochloride [366-70-1]; Up 200; 15.6uM; MCF7; HT_HG-U133A	HFE CYP2B6 SPINK2 IFNA2 PRF1 COL1A2	3.06e-04	195	106	6	5452_UP
Drug	chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A	HFE CELSR1 IGFBP5 ATP2B4 COL1A1 COL1A2	3.06e-04	195	106	6	6176_UP
Drug	Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A	HFE CD52 SLC24A1 ATP2B4 COL1A1 COL1A2	3.06e-04	195	106	6	3401_UP
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CD52 CYP2B6 DLK1 LAPTM5 TRPV6 COL1A1	3.06e-04	195	106	6	4162_UP
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	CELSR1 IGFBP5 TRPM3 CD53 LY9 SLC24A1	3.06e-04	195	106	6	4368_UP
Drug	Famprofazone [22881-35-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	TMEM53 DDX60 RNASE4 PRF1 ACKR2 COL1A1	3.06e-04	195	106	6	3834_UP
Drug	Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A	HFE CD52 ATP2B4 COL1A1 COL1A2 EPHB1	3.06e-04	195	106	6	4063_UP
Drug	Ribostamycin sulfate salt [53797-35-6]; Up 200; 7.2uM; HL60; HT_HG-U133A	HFE TP53I11 IGFBP5 ACKR2 SLC24A1 GRAMD1C	3.06e-04	195	106	6	2705_UP
Drug	Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; MCF7; HT_HG-U133A	HFE HTR4 GPR85 IGFBP5 ACKR2 SLC24A1	3.06e-04	195	106	6	3199_UP
Drug	DO 897/99; Up 200; 8.2uM; MCF7; HT_HG-U133A	HFE CD52 HTR4 SLC24A1 COL1A1 EPHB1	3.15e-04	196	106	6	2877_UP
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A	CYP2B6 GPR37 HUWE1 DEFA4 THPO ATP2B4	3.15e-04	196	106	6	5622_UP
Drug	17-AAG; Down 200; 1uM; PC3; HG-U133A	HFE TP53I11 CD84 DEFA4 TRPM3 ASIP	3.15e-04	196	106	6	432_DN
Drug	Brinzolamide [138890-62-7]; Up 200; 10.4uM; PC3; HT_HG-U133A	HTR4 GPR85 CD84 DEFA4 IGFBP5 COL1A1	3.15e-04	196	106	6	6670_UP
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; PC3; HT_HG-U133A	HFE THPO IGSF1 LY9 SLC24A1 EPHB1	3.15e-04	196	106	6	4231_UP
Drug	Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TP53I11 LAPTM5 IGFBP5 CD53 TRPV6 COL1A1	3.15e-04	196	106	6	3192_DN
Drug	Hesperetin [520-33-2]; Up 200; 13.2uM; HL60; HG-U133A	HTR4 SLC10A3 CLEC4M CD84 PRF1 IGSF1	3.15e-04	196	106	6	2031_UP
Drug	flufenacet	DEFA1 DEFA3	3.18e-04	6	106	2	CID000086429
Drug	2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine	COL1A1 COL1A2	3.18e-04	6	106	2	ctd:C502971
Drug	2,2',4,4',5-pentachlorobiphenyl	CYP2B6 SERPINA7	3.18e-04	6	106	2	ctd:C500336
Drug	Kathon	SIRPA THPO	3.18e-04	6	106	2	CID000033528
Drug	Boron	BGLAP COL1A1	3.18e-04	6	106	2	ctd:D001895
Drug	testosterone acetate	DEFA1 DEFA3	3.18e-04	6	106	2	CID000092145
Drug	Remifemin	BGLAP COL1A2	3.18e-04	6	106	2	ctd:C073419
Drug	AR-L57	DEFA1 DEFA3	3.18e-04	6	106	2	CID000156890
Drug	vitamin D3	CYP2B6 BGLAP TGFBI TRPV6 ACKR2 ATP2B4 COL1A1	3.20e-04	277	106	7	CID000002735
Drug	Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A	HFE HUWE1 THPO IGFBP5 SLC24A1 COL1A1	3.24e-04	197	106	6	5637_UP
Drug	Phentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; PC3; HT_HG-U133A	HFE DEFA4 IGFBP5 GRAMD1C SERPINA7 COL1A1	3.24e-04	197	106	6	4336_UP
Drug	Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A	TP53I11 HUWE1 LAPTM5 SLC24A1 GNRH2 EPHB1	3.24e-04	197	106	6	4116_UP
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A	HTR4 GPR85 TP53I11 GREB1 GRAMD1C COL1A1	3.24e-04	197	106	6	6105_DN
Drug	estradiol, USP; Up 200; 0.1uM; MCF7; HG-U133A	HTR4 SLC2A6 ASIP GNRH2 GPRC5B COL1A2	3.24e-04	197	106	6	365_UP
Drug	Piracetam [7491-74-9]; Up 200; 28.2uM; PC3; HT_HG-U133A	HFE GPR85 LAPTM5 PRF1 GRAMD1C COL1A1	3.24e-04	197	106	6	5043_UP
Drug	Methylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A	HFE CELSR1 IGFBP5 LY9 ATP2B4 EPHB1	3.24e-04	197	106	6	4113_UP
Drug	Esculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CD52 DDX60 TP53I11 ACKR2 SLC24A1 COL1A1	3.24e-04	197	106	6	3390_UP
Drug	Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HFE HTR4 GPR37 ACKR2 SLC24A1 EPHB1	3.24e-04	197	106	6	3339_UP
Drug	Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	TMEM53 ITGA1 THPO TRPM3 LY9 COL1A2	3.24e-04	197	106	6	6605_UP
Disease	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	COL1A1 COL1A2	1.18e-05	2	102	2	C0268345
Disease	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	COL1A1 COL1A2	1.18e-05	2	102	2	C4551623
Disease	Osteogenesis imperfecta with normal sclerae, dominant form	COL1A1 COL1A2	1.18e-05	2	102	2	cv:C0268363
Disease	Osteogenesis imperfecta type III	COL1A1 COL1A2	1.18e-05	2	102	2	cv:C0268362
Disease	Osteogenesis imperfecta, perinatal lethal	COL1A1 COL1A2	1.18e-05	2	102	2	cv:C0268358
Disease	OSTEOGENESIS IMPERFECTA, TYPE III	COL1A1 COL1A2	1.18e-05	2	102	2	259420
Disease	osteogenesis imperfecta type 3 (is_implicated_in)	COL1A1 COL1A2	1.18e-05	2	102	2	DOID:0110339 (is_implicated_in)
Disease	osteogenesis imperfecta type 4 (is_implicated_in)	COL1A1 COL1A2	1.18e-05	2	102	2	DOID:0110340 (is_implicated_in)
Disease	osteogenesis imperfecta type 2 (is_implicated_in)	COL1A1 COL1A2	1.18e-05	2	102	2	DOID:0110341 (is_implicated_in)
Disease	OSTEOGENESIS IMPERFECTA, TYPE IV	COL1A1 COL1A2	1.18e-05	2	102	2	166220
Disease	OSTEOGENESIS IMPERFECTA, TYPE II	COL1A1 COL1A2	1.18e-05	2	102	2	166210
Disease	osteogenesis imperfecta (is_implicated_in)	COL1A1 COL1A2	3.54e-05	3	102	2	DOID:12347 (is_implicated_in)
Disease	osteogenesis imperfecta type 3 (implicated_via_orthology)	COL1A1 COL1A2	3.54e-05	3	102	2	DOID:0110339 (implicated_via_orthology)
Disease	OSTEOPOROSIS	COL1A1 COL1A2	7.07e-05	4	102	2	166710
Disease	Liver Cirrhosis, Experimental	SLC22A23 SLC44A2 IFNA2 LAPTM5 RNASE4 PLA2G12A CD53 SERPINA7 COL1A1 CNDP1 COL1A2	7.69e-05	774	102	11	C0023893
Disease	Heart valve disease	BGLAP COL1A1 COL1A2	9.84e-05	26	102	3	C0018824
Disease	Osteogenesis imperfecta, dominant perinatal lethal	COL1A1 COL1A2	1.18e-04	5	102	2	C0268358
Disease	osteogenesis imperfecta (implicated_via_orthology)	COL1A1 COL1A2	1.18e-04	5	102	2	DOID:12347 (implicated_via_orthology)
Disease	Lobstein Disease	COL1A1 COL1A2	1.18e-04	5	102	2	C0023931
Disease	Ehlers-Danlos Syndrome	COL1A1 COL1A2	1.18e-04	5	102	2	C0013720
Disease	osteoarthritis (is_implicated_in)	HFE DDR2 BGLAP	1.23e-04	28	102	3	DOID:8398 (is_implicated_in)
Disease	osteoporosis (is_implicated_in)	BGLAP COL1A1 COL1A2	1.68e-04	31	102	3	DOID:11476 (is_implicated_in)
Disease	Osteoporosis	COL1A1 COL1A2	1.76e-04	6	102	2	cv:C0029456
Disease	Ehlers-Danlos syndrome (implicated_via_orthology)	COL1A1 COL1A2	1.76e-04	6	102	2	DOID:13359 (implicated_via_orthology)
Disease	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	VANGL2 CELSR1	3.27e-04	8	102	2	C3891448
Disease	factor VIII measurement	F12 SLC38A2 SLC2A6	3.61e-04	40	102	3	EFO_0004630
Disease	neutrophil measurement	HTR4 DEFA1 DEFA3 DEFA4 TMEM41B	3.82e-04	177	102	5	EFO_0803548
Disease	Thrombocytosis, Autosomal Dominant	IFNA2 THPO	4.19e-04	9	102	2	C3489628
Disease	Osteogenesis imperfecta type IV (disorder)	COL1A1 COL1A2	5.23e-04	10	102	2	C0268363
Disease	beta thalassemia (is_implicated_in)	HFE COL1A1	5.23e-04	10	102	2	DOID:12241 (is_implicated_in)
Disease	ankyrin-2 measurement	OPTC ATP2B4	5.23e-04	10	102	2	EFO_0021874
Disease	Early Pregnancy Loss	CD84 TGFBI COL1A1 COL1A2	5.67e-04	109	102	4	C3830362
Disease	Spontaneous abortion	CD84 TGFBI COL1A1 COL1A2	5.67e-04	109	102	4	C0000786
Disease	Miscarriage	CD84 TGFBI COL1A1 COL1A2	5.67e-04	109	102	4	C4552766
Disease	Abortion, Tubal	CD84 TGFBI COL1A1 COL1A2	5.67e-04	109	102	4	C0000822
Disease	monocyte count	CD52 SPINK2 DOCK8 DDR2 PM20D1 CLEC4M CD84 DEFA3 DEFA4 PKD1 ACKR2 LY9 ATP2B4	6.27e-04	1320	102	13	EFO_0005091
Disease	Osteogenesis imperfecta type III (disorder)	COL1A1 COL1A2	6.38e-04	11	102	2	C0268362
Disease	Diarrhea	IFNA2 GUCY2C	6.38e-04	11	102	2	C0011991
Disease	cholesteryl esters to total lipids in small VLDL percentage	TTC39B TMEM116 ABCA6	6.58e-04	49	102	3	EFO_0022256
Disease	intracranial aneurysm (is_implicated_in)	PKD1 COL1A2	7.64e-04	12	102	2	DOID:10941 (is_implicated_in)
Disease	Thrombocythemia, Essential	IFNA2 THPO	7.64e-04	12	102	2	C0040028
Disease	platelet measurement	SPINK2 DOCK8 SIRPA F12 THPO TRPM3	8.05e-04	315	102	6	EFO_0005036
Disease	Familial thoracic aortic aneurysm and aortic dissection	PKD1 COL1A1 COL1A2	8.29e-04	53	102	3	C4707243
Disease	Osteogenesis Imperfecta	COL1A1 COL1A2	9.00e-04	13	102	2	C0029434
Disease	aplastic anemia (is_implicated_in)	THPO PRF1	9.00e-04	13	102	2	DOID:12449 (is_implicated_in)
Disease	icos ligand measurement	DEFA1 DEFA4	9.00e-04	13	102	2	EFO_0020460
Disease	Hepatitis C	HFE IFNA2	1.21e-03	15	102	2	C0019196
Disease	YKL40 measurement	OPTC ATP2B4	1.21e-03	15	102	2	EFO_0004869
Disease	lifestyle measurement, anxiety disorder measurement	TRHDE SIRPA TRPM3 ACKR2	1.33e-03	137	102	4	EFO_0007795, EFO_0010724
Disease	SLAM family member 7 measurement	DDR2 LY9	1.56e-03	17	102	2	EFO_0008287
Disease	Oral Submucous Fibrosis	COL1A1 COL1A2	1.75e-03	18	102	2	C0029172
Disease	Anorexia	HTR4 IFNA2	1.75e-03	18	102	2	C0003123
Disease	cardiomyopathy (is_implicated_in)	HFE POMT1	1.95e-03	19	102	2	DOID:0050700 (is_implicated_in)
Disease	sensorineural hearing loss (implicated_via_orthology)	SLC44A4 SLC7A14	1.95e-03	19	102	2	DOID:10003 (implicated_via_orthology)
Disease	Osteogenesis imperfecta	COL1A1 COL1A2	2.38e-03	21	102	2	cv:C0029434
Disease	Lymphoma, Diffuse	IFNA2 PRF1	2.38e-03	21	102	2	C3714542
Disease	Low Grade Lymphoma (neoplasm)	IFNA2 PRF1	2.38e-03	21	102	2	C0079747
Disease	Lymphoma, Intermediate-Grade	IFNA2 PRF1	2.38e-03	21	102	2	C0079741
Disease	High Grade Lymphoma (neoplasm)	IFNA2 PRF1	2.38e-03	21	102	2	C0079740
Disease	Diffuse Mixed-Cell Lymphoma	IFNA2 PRF1	2.38e-03	21	102	2	C0079757
Disease	Lymphoma, Undifferentiated	IFNA2 PRF1	2.38e-03	21	102	2	C0024306
Disease	Reticulosarcoma	IFNA2 PRF1	2.38e-03	21	102	2	C0024302
Disease	Lymphoma, Mixed-Cell	IFNA2 PRF1	2.38e-03	21	102	2	C0024304
Disease	total iron binding capacity	HFE SLC44A4 EPHB1	2.53e-03	78	102	3	EFO_0006334
Disease	Lymphoma, Non-Hodgkin, Familial	IFNA2 PRF1	2.61e-03	22	102	2	C4721532
Disease	Lymphoma, Small Noncleaved-Cell	IFNA2 PRF1	2.61e-03	22	102	2	C0079770
Disease	hypothyroidism (biomarker_via_orthology)	SLC26A5 SERPINA7 COL1A2	2.72e-03	80	102	3	DOID:1459 (biomarker_via_orthology)
Disease	Septicemia	IFNA2 TGFBI	3.11e-03	24	102	2	C0036690
Disease	Sepsis	IFNA2 TGFBI	3.11e-03	24	102	2	C0243026
Disease	Severe Sepsis	IFNA2 TGFBI	3.11e-03	24	102	2	C1719672
Disease	Pyemia	IFNA2 TGFBI	3.11e-03	24	102	2	C0034189
Disease	lymphocyte:monocyte ratio	CD52 DEFA3 PRF1 ACKR2 LY9	3.30e-03	288	102	5	EFO_0600088

Protein segments in the cluster

Peptide	Gene	Start	Entry
LRALLMVLVFLLVVS	VANGL2	181	Q9ULK5
LLAVTMLAVLLSLRF	TRHDE	51	Q9UKU6
LSGNLLLLMVLLRYV	ACKR2	61	O00590
MALFVRLLALALALA	TGFBI	1	Q15582
MSIFVLLLVLLNVTL	GRAMD1C	561	Q8IYS0
LLMSFFILLLIILLA	CD53	81	P19397
MELSVLLFLALLTGL	CYP2B6	1	P20813
MTIHILILLLLLAFS	ADM5	1	C9JUS6
LLLSVIFNILLSLAM	ATP13A4	971	Q4VNC1
ASRLLLLPRVLLTMA	CUTA	31	O60888
SMLLLDGLIYLLLAL	ABCA6	401	Q8N139
AALLVAFVLLSLVRM	CELSR1	2481	Q9NYQ6
AFVLLSLVRMLRSNL	CELSR1	2486	Q9NYQ6
MTATEALLRVLLLLL	DLK1	1	P80370
AGLLMSALTVFILIL	ATP2B4	366	P23634
MDVTRLLLATLLVFL	ASIP	1	P42127
LMSLGILLLLVSRLL	TP53I11	156	O14683
GAVVLLLLVALLMLR	GUCY2C	441	P25092
SVMALLQALELLLIR	PM20D1	161	Q6GTS8
ALLGLSLLLMLLLYV	ABHD14A	36	Q9BUJ0
MALDYLLLLLLASAV	EPHB1	1	P54762
RPALTLLLLLMAAVV	PLA2G12A	6	Q9BZM1
ILDLIMLILFFLDSL	SLC24A1	566	O60721
VLLFLMLLFVISSIA	SLC24A1	1046	O60721
LQFLSVLSRMLVRLT	GREB1	1356	Q4ZG55
RMLLVLFLLLPILSS	DDR2	6	Q16832
MRATAIVLLLALTLA	SPINK9	1	Q5DT21
RILETLVMLLLLALL	LMBR1	146	Q8WVP7
HFPLSITLVLRLMLL	DDX60	1361	Q8IY21
FPLSITLVLRLMLLA	DDX60L	1346	Q5H9U9
RATRQEMLFLALLLL	PF4V1	11	P10720
MRLLAFLSLLALVLQ	OPTC	1	Q9UBM4
ILLSYALILRAMLVI	OR51I1	216	Q9H343
SLLALAMLQLSLRRL	SLC10A3	426	P09131
MAARLLLLGILLLLL	PRF1	1	P14222
MGRRALLLLLLSFLA	PRCP	1	P42785
MVLLTAVLLLLAAYA	IGFBP5	1	P24593
RPALLLLMLLQTAVL	HFE	6	Q30201
LQLLVFTALAILIMR	DPY19L2	541	Q6NUT2
LLSAFAGLLLLMLLI	ITGA1	1146	P56199
VRLLSVLIAALTMDL	SLC2A6	321	Q9UGQ3
MLLLAVLNFTALLIE	HUWE1	91	Q7Z6Z7
TLELMSFILALFTLI	OR6C76	191	A6NM76
VSMRLLAAALLLLLL	CXCL14	11	O95715
MALSVLRLALLLLAV	SPINK2	1	P20155
MSAVGLVLLVLALRL	PKD1L2	1	Q7Z442
MRALTLLALLALAAL	BGLAP	1	P02818
GALITLLLMLILLVR	GPRC5B	66	Q9NZH0
RLMLLESVLIFFNLL	POMT1	151	Q9Y6A1
VLRLLLVTMGLLFVL	FRMD5	501	Q7Z6J6
LVTMGLLFVLLLLLI	FRMD5	506	Q7Z6J6
MLSFVDTRTLLLLAV	COL1A2	1	P08123
IRLSLIMQLVALLLV	IGSF1	521	Q8N6C5
ALLARMSRLLLLLLL	GPR37	6	O15354
MRTLAILAAILLVAL	DEFA1	1	P59665
LPTLISMRLEFLRIL	DOCK8	1086	Q8NF50
MRTLAILAAILLVAL	DEFA3	1	P59666
GLLLFLLSLMTLTLF	MT-CYB	231	P00156
VLLVLVLLILSMRRH	CDH20	631	Q9HBT6
MQRLVLLLAISLLLY	DEFB104A	1	Q8WTQ1
ARNIVLSFMLLLLLL	BCE1	66	O60756
VLLTFLSTVILMAIL	HTR4	21	Q13639
MKRFLFLLLTISLLV	CD52	1	P31358
MRLHLLLLILLLFSI	DEFB109B	1	Q30KR1
MALTFALLVALLVLS	IFNA2	1	P01563
VLQTSLLFLLMGLRA	LY9	31	Q9HBG7
PSRLLAILLFLLAML	EFNA5	211	P52803
ISAQVLLSLRILLLM	GBF1	1216	Q92538
GFMLLLALILLATQL	GPR85	186	P60893
SLLFIILLRFLAGIM	SLC44A2	246	Q8IWA5
LAVLEAILLLMLIFL	SLC44A4	316	Q53GD3
MASSRRGLLLLLLLT	GNRH2	1	O43555
ISLMTLLLFVVLLAF	EQTN	186	Q9NQ60
MRIIALLAAILLVAL	DEFA4	1	P12838
MVRLAAELLLLLGLL	ISM1	1	B1AKI9
MRRLLLVTSLVVVLL	PRAP1	1	Q96NZ9
LRSLLVYMLFLLVTL	PKD1	3671	P98161
TSLLAMTRTFLIFRL	OR1P1	166	Q8NH06
MRALLLLGFLLVSLE	F12	1	P00748
LIMFILTATLLILSL	TAS2R39	221	P59534
LIMFILAATLLILSL	TAS2R40	206	P59535
VMLLILSLFLLIFDS	TAS2R42	131	Q7RTR8
LAILLILLFTMLLRL	SERTM2	46	A0A1B0GWG4
LMAVILSVTLLLIFS	RNF183	166	Q96D59
IMTALQIASFILLRL	GIMAP4	311	Q9NUV9
SFLLITMLFIISLSL	LAPTM5	66	Q13571
LLLFMILTALASLLQ	SLC22A23	496	A1A5C7
LASLMILLVILATGF	SLC26A5	416	P58743
TLLVALLMAALYLVR	SIRPA	381	P78324
MALRRLLLLLLLSLE	SHISA6	1	Q6ZSJ9
LLSVLAMFFLLVLIL	CD84	226	Q9UIB8
LLIFLITMLILVTAN	MT-ND5	121	P03915
ILFIIMLLAVAILSL	SLC38A4	106	Q969I6
LVLQLLSFMLLAGVL	CLEC4M	51	Q9H2X3
GRMAASLLAVLLLLL	CNDP1	6	Q96KN2
SLLAVLLLLLERGMF	CNDP1	11	Q96KN2
MFSFVDLRLLLLLAA	COL1A1	1	P02452
ALLALLVSLRDLIEM	SLC7A14	396	Q8TBB6
MALQRTHSLLLLLLL	RNASE4	1	P34096
MLSLLPARIIRLLEF	TTC39B	311	Q5VTQ0
RAALMVFLLLTTLLL	PROM2	151	Q8N271
LLLIVRLAVLMAVTL	SLC38A2	371	Q96QD8
LIAILLFSVGMILRL	TRPM3	971	Q9HCF6
LLVLLLVILARMFQT	SUSD4	331	Q5VX71
MLLLALLLLLRLATL	TMEM115	171	Q12893
FMLLILERSTRSILF	SERPINA7	391	P05543
AAMLRLLLLVAFALV	TMEM53	166	Q6P2H8
FVLSLLTIMVLLIRA	TMEM116	96	Q8NCL8
AFAIIATLLMLNLLI	TRPV6	601	Q9H1D0
MLEGALTFLVILLSL	UBR3	761	Q6ZT12
RMSLLILVSIFLSAA	TMEM41B	51	Q5BJD5
LFILLSLALISDAMV	TMIGD3	61	P0DMS9
MLLLLSDQLLLTALR	ZNF34	1	Q8IZ26
LALDISMLRLFETFL	XKR8	126	Q9H6D3
LLLVVMLLLTARLTL	THPO	6	P40225
EIFLVSILLLTLMLV	NALCN	1016	Q8IZF0